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CRITERIA FOR EVOLUTION OF SUCCESSFUL PROTEINS: FOLD
FITNESS AND DOMAIN DYNAMICS EXPLORED

Tyrel Bryan
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Ph.D., Chemistry, University of New Mexico 2014

ABSTRACT
The Haloacid Dehalogenase Superfamily (HADSF) is a ubiquitous family
of enzyme with more than 32,000 members. A variety of reactions are catalyzed by HAD
members, but a majority of HAD members are phosphatases. Dephosphorlyation of
organophosphate metabolites are carried out in the conserved Rossmann-like core
domain. The Rossman-like core domain houses the conserved active site residues
necessary for catalysis and also supports domain inserts associated with substrate
binding.
This dissertation will focus primarily on investigating fold fitness and
domain dynamics of HAD proteins more specifically three C2 capped proteins. The first
part will focus on whether or not the prevailing tenet that "Catalytic Function Comes at
the Expense of Protein Fold Stability" is applicable to the HADSF phosphatase. To test
function at the cost of stability site directed mutagenesis was used to replace catalytic
residues and used an array of techniques (CD/Fluorescence/SAXS) to monitored
denaturation to evaluate stability in the resulting mutants. From denature results we
v

conclude that although most catalytic residues play no role in stability, good or bad, one
in particular Asp2 of DXD squiggle shows to be necessary for not only activity but
stability as well. To identify what about the residue is essential to stability the side chain
and interacting residues were examined.
The Rossmann-like catalytic core domain is a robust domain, and to test
the co-evolution of the cap and catalytic domains as a "coupled folding and catalytic
units" will be examined. The structural co-dependency was tested by creating truncations
of the catalytic and cap domains and identifying stability and activity of each domain and
chimeric C2 capped proteins. Thermal denature of truncations and chimeric proteins
reveal stability of each domain separately while the chimeric stability establish a robust
core Rossmann-like catalytic domain.
As previously discussed the cap domain increases function by increasing
recognition of substrates. To examine the cap domains role in substrate-induced-fit we
examined changes in protein solution conformation using small angle X-ray scattering
(SAXS). Because HAD proteins have evolved separate domains for catalysis and
recognition SAXS will also be used to investigate changes in conformation change due to
changes in domain-domain interfacing residues. Solution scattering of Bt4131 help
demonstrate an induced-fit mechanism for HAD proteins. In the presence of VO3
(phosphate analog) we see closure of cap domain whereas sugar moiety does not initiate
closure of domain.
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CHAPTER ONE
Protein Structural Elucidation and Evolutionary Markers
1.1 Haloacid Dehalogenase Superfamily
The Haloacid Dehalogenase Superfamily (HADSF) is a ubiquitous family of
enzymes (1,2). Although most family members are phosphotransferases, the family was
named after the first characterized member, 2-haloacid dehalogenase (3,4). The HADSF
enzymes are found in all forms of life and typically there are ten or more different
HADSF enzymes per organism. The chemistry catalyzed by this enzyme includes
phosphate and carbon group transfer processes (Figure 1.1) (1). The phosphatases,
enzymes that catalyze phosphate ester hydrolysis, make up the majority of the HADSF.
Phosphorylated biomolecules are as varied in structure and function as they are abundant
in the cell. Therefore, phosphoryl group recycling is central in living systems, and the
large size of the HADSF phosphatase subfamily can, in part, be attributed to the high
demand for cellular phosphatases.
The fact that the HADSF phosphatases greatly outnumber the phosphatases from
other superfamilies suggests that the HADSF is highly effective at evolving novel
phosphatases. For instance, the phosphatases of E. coli derive from seven different
enzyme superfamilies, yet the twenty-nine HADSF phosphatases present outnumber the
combined sum of the phosphatases from the other six superfamilies. The dominance and
success can be associated with the expanded library of substrates that support catalysis
also known as "evolutionary exploration of substrate space" (5), but what special about
1

the HADSF has allowed this proliferation in living organism. Among a set of reactions
catalyzed by the HADSF, the protein members have a conserved core domain which
houses the active residues conserved in all HAD proteins.
With the vast amount of information available through X-ray crystal structures and
bioinformatic networks a possible explanation for the evolutionary success of the
HADSF can be proposed.

Figure 1.1: General reactions catalyzed by HAD proteins. RED: protein residues whereas
BLUE represents substrates or coordinating water.

1.2 HADSF Rossman Core Domain
The core domains of the HADSF members consist of a central -sheet in between
-helices, a topology that is reminiscent of Rossmannoid class of / folds. Unlike other
2

Rossmann-like folds, the HADSF fold has four conserved motifs that play a significant
role in catalysis (Figure 1.2) (3, 6). The four conserved residues are associated with the
active site of the core domain in all HADs. The active site of the core domain is the
binding site for the phosphate moiety which is transferred from the phosphate ester
substrate to in most cases a solvent water molecule.

B

A

Figure 1.2: A. Cartoon representation of conserved HADSF motifs, each Motif is colored
individually. B. represents monomer of KDN9P (PDB: 3E8M) colored residues correspond to
motif coloring of A.

The conserved motifs of HADs, residing in the active site of the protein, consist
of Motif I with a conserved Asp with the sequence DxD, Motif II with a loop 2 a
conserved Ser/Thr, Motif III with a loop 3 conserved Arg/Lys, and Motif IV with a loop
3

4 conserved Asp. Because each motif includes conserved residues that are responsible for
specific binding functions within the active site, sequence alignment allows for
identification of HADSF members.
The role of the conserved aspartates (DxD) in Motif I, involving binding of the
metal cofactor Mg2+, is the cornerstone to catalysis. Asp1 acts as a nucleophile and
creates an aspartyl-phosphoryl intermediate and Asp2 act as a general acid base to
regenerate enzyme and the alcohol leaving group (7-9). Motifs II and III include
conserved Ser/Thr and Lys/Arg respectively, which assist in stabilizing high energy
intermediates. Loop 4 associated with Motif IV consists of two Asp residues, which
partner with the aspartates in Motif I to bind Mg2+ (3, 4, 7, 10-12). Although the catalytic
core comprised of the four motifs described above motifs is conserved in HADs, diversity
in substrate recognition is directed by inserts into the Rossmann-like core domain. These
insert or "caps" aid in active site shielding and substrate recognition.

1.3 Incorporation of Cap Domain and Expansion of Substrate Recognition
The caps found in a majority of HADSF proteins are categorized into subfamilies
that are classified by size and insert point. The three subfamilies are: C0 comprise HAD
proteins that include small loops or no cap, C1 and C2 capped proteins are distinguished
by insertion point of cap domain (between loops 1 & 2 or between loop 2 & 3
respectively) Figure 1.3. As shown in Figure 1.2 substrate specificity is usually
dominated by interactions with cap domains or extended loops (11-13).

4

Two well-studied C0 HAD proteins include 2-keto-3-deoxy-D-glycero-D-galacto9-phosphatase (KDN9P) from the 8KDOP subfamily and D-glycero-D-manno-Heptose1,7-bisphosphate phosphatase (GmhB) from the HisB subfamily (11, 14). The X-ray
structure shows that KDN9P contains a -loop- insert at the same C1 insert site in the
core domain. This extended loop functions in oligermerizing KDN9P monomers into a
functional tetramer (14) GmhB of the C0 subfamily belonging to the HisB clade does not
possess a true cap domain, but instead contains three ornate loops which create a rounded
barrier for active site and bound substrate (11). In both of these enzymes, the inserted
loops act to increase substrate affinity and to create a more active conformation.

Figure 1.3: Representation of the HADSF subfamilies based on cap inserts and insert site.
BLUE represents the Rossmann-like core domain and ORANGE represents the inserted cap
domain.

The C1 subfamily proteins are distinguished by possessing one of two types of
cap inserts, including an -helical cap or a small + cap. One of the more studied C1
(-helical) capped proteins is -phosphoglucomutase (PGM) from Lactococcus lactis.
5

PGM catalyzes the interconversion of -D-glucose-1-phosphate to D-glucose-6phohspate. Important to substrate conversion is the cap domains and conserved residues
that bind the substrate (10, 15).
The C2 subfamily is divided into 2 cap types, the NagD (type A) and Cof-type
phosphatases (type B) (1). Both caps incorporate an + domain consisting of at least
three -strands. Two crystallized C2B proteins in these subfamilies include Bacteroides
thetaiotaomicron Bt4131 and Escherichia coli YbiV. Both proteins have elaborate cap
inserts with C2B topologies (12, 17, and 18). The results of substrate screening show that
both proteins have affinities for sugar phosphates. The determination of classes and
categorizing of HAD proteins has been simplified as a result of X-ray crystallographic
studies which reveal secondary and tertiary structural features. However, in cases where
X-ray structural information is lacking other methods are needed for elucidating
subfamilies to which HADs belong.

1.4 Benefits of Neutron Crystallography
From the time of the first structure elucidations by John Kendrew and Max Perutz
to today where numerous structures have been deposited into the Protein Data Bank, Xray crystallography has found numerous applications to enzymes (19, 20). The
advancements in X-ray energy sources and computational programs have allowed an
exponential growth of the known enzyme structures (21-26). Although X-ray
crystallography is a powerful technique it has some important limitations. In particular,
X-ray diffraction does not reveal the positions of hydrogen atoms owing to their small
6

electron density. Although positions of the majority of hydrogen atoms in proteins can be
assumed owing to the connectivity to amino acid residues, those that are in active site
residues involved in catalysis exist in modified protonation states. Thus, the ability to
locate these types of hydrogen can provide overwhelming insight into modes of catalysis
( 27-30). It is fortunate that, in contrast to the X-ray method, neutron crystallographic
analysis of appropriate deuterated analogs provides data that can be used to identify
protonation states of enzymes (32).
The ability to resolve the positions of hydrogen atoms within the structures of
HADs is invaluable (Figure 1.4). As a result, incorporation of neutron crystallography
into the study of members of this superfamily will enable a better understanding of the
mechanism for the phosphoryl transfer reactions they catalyze. Because most HAD
proteins contain two domains that interact through solvent linkers, their activities for the
most part (C1 and C2 subfamilies) involve desolvation of the active site and substrate
from bulk solvent. Although X-ray crystallography along with other techniques have
already been used to observe specific conformations in which the HADs exist (10, 16,
33), results coming from Neutron crystallographic studies will serve as a third source of
information about the domain dynamics and solution conformations of these enzymes.

7

Figure 1.4: 2Fo-Fc neutron density map (BLUE) contoured 1 of His44 and Trp29 of KDN9P.
The exchanged deuteriums are shown in white

1.5 Small Angle Xray Scattering
Small angle X-ray scattering (SAXS) is an elastic scattering technique that has
been used to investigate the structures of biological macromolecules in solution.
Although it has a lower resolution than do X-ray and Neutron crystallography, SAXS can
be used to investigate almost biomolecules under near physiological conditions as
demonstrated by its applications to exploring features of flexible protein systems, protein
complexes, and systems as large as viral particles (36-38)
X-ray scattering data collected on samples in solution is a collection of scattering
intensities as a function of scattering angle. The difference between electron densities of
solvent and solute can be used to gain structural information about the solute. Because
samples in solution lack crystal lattices and adopt random orientations, the resulting X8

ray intensities can be fit to a one dimensional curve (I(q)) averaged over all orientations
Eq. 1.1 (39). Isotropic scattering is dependent on the modulus of the momentum transfer
q (q = 4πsin(θ)/λ) where 2θ is the scattering angle and λ incident wavelength. Data is
collected for both the solvent (exact match buffer) and solute (buffer + sample(s)), and
the subtracted curve is the radially average used for further processing.
𝐼(𝑞) = 〈𝐼(𝑞)〉𝛺 = 〈𝐴(𝑞)𝐴∗ (𝑞)〉𝛺

Eq. 1.1

Eq. 1.1: I(s) Describes the intensity averaged over all orientations (Ω) where A(s) is a Fourier
Transformation of the excess scattering length distance.

Several parameters can be elucidated from the scattering curve. The parameters

include (MM) molecular mass, (Rg) radius of gyration, (Vp) hydrated particle volume,
and (dmax) maximum diameter of particle. The Rg value can be determined two ways
including using the Guinier approximation and the Pair Distribution function Eq. 1.2-3.
The Rg value is essentially the root mean square distance from the center of gravity
(42,43).
1 2 2
)

𝐼(𝑠) = 𝐼(0)𝑒 (−3𝑅𝑔𝑞
𝑝(𝑟) =

𝑟2 ∞ 2
sin 𝑞𝑟
∫ 𝑞 𝐼(𝑞)
𝑑𝑞
2
2𝜋 0
𝑞𝑟

Eq. 1.2
Eq. 1.3

Eq. 1.2-3: Eq. 1.2 describes definition of Guinier equation. Equation 1.3 describes the Fourier
transformation of the scattering intensity to yield the distance distribution function p(r)

Molecular mass can be calculated based a knowing the intensities arising from at
least two known concentrations of a well-studied sample with known particle size (for
example, Bovine Serum Albumin, BSA or lysozyme) (40). Possible determination of
MM can also be made using the known scattering of water (41). In some instances
9

determination of MM is less useful than is the hydrated particle volume (Vp) owing to the
dependence on concentrations of the sample. Vp is an alternative estimation of MM
estimated by the electron density of the particle estimated on Parod's equation Eq. 1.4
(44).

𝑉𝑝 =

2𝜋 2 𝐼(0)
𝑄

∞

𝑄 = ∫0 𝑞 2 𝐼(𝑞) ∙ 𝑑𝑞

.

Eq. 1.4

Eq. 1.4: Parod's equation

Once initial interpretation of scattering data has been completed, advancements in
low resolution modeling makes it possible to create ab intio models using an array of
techniques including dummy atom modeling such as DAMMIN (45) and sequence based
modeling such as GASBOR (46). Implementation of other programs enable a comparison
of the structure with models created by using high resolution structure data (X-ray, NMR
Structures) using CRYSOL (47). Together the advancements in Synchrotron X-ray beam
intensities and programs dedicated to understanding scattering profiles have allowed the
SAXS technique to be utilized to gain structural information about biomolecules under
near physiological conditions.

1.6 The Multi-Domain Protein Pyruvate Phosphate Dikinase
Pyruvate phosphate dikinase (PPDK) is a multi-domain protein that catalyzes the
conversion of ATP, phosphate, and pyruvate into AMP, pyrophosphate, and
phosphoenolpyruvate by a pathway involving two partial reactions. PPDK consist of
10

three separate domains including a N-terminal nucleotide binding domain reminiscent of
an ATP grasp domain, C-terminal α/β barrel PEP/pyruvate binding domain, and a central
domain. The two partial reactions involving ATP promoted N-phosphorylation of a
histidine residue in the central domain followed by central domain swiveling and
phosphoryl transfer to pyruvate bound in the C-terminal domain (Figure 1.5).

Figure 1.5: Displays the general reaction coordinates for PPDK. Each partial reaction is
reversible in the presence of necessary substrates.

PPDK, whose crystal structure was solved earlier (48), is a 96 kDa homodimer
created by interactions between α/β barrel domains (48). One of the two protein
conformations (PDB: 1DIK) contains the central domain docked to ATP-grasp domain
11

(48). To crystallize the second conformation where the central domain is located near the
PEP binding domain, a triple mutant of residues near the nucleotide binding domain were
created in order to negate binding interactions between grasp-domain and central domain.
(35).

Figure 1.X: Crystal representation of PPDK dimer (PDB: 1DIK). GREEN: Nucleotide
binding domain, YELLOW: Central domain and BLUE: α/β barrel PEP binding domain.

1.7. Summary
Although HADSF proteins are mechanistically unlike the colossal 96 kDa PPDK,
both proteins have novel features that can be probed using techniques other than X-ray
crystallography. The HADSF proteins have been shown to have evolved a very large
12

range of substrates for catalysis owing to the presence of a prominent and core domain
robust fold. PPDKs ability to create an efficient and unique catalytic pathway through
connection of domains to carry out partial reactions guided by domain swiveling is highly
intriguing and warrants further investigation. An important common feature of both
proteins is their use of multiple domains and ability to take advantage of the strengths of
protein fold and structure. Research serving as the foundation of this dissertation focuses
on structural adaptations of proteins in the HADSF and PPDK. A reoccurring theme
throughout the chapters is protein stability, domain dynamics and structure.
In discussions of enzymes, a majority of attention is often given to mechanism
and efficiency and not to protein fold and stability. It is known that the HADSF proteins
play an important role as phosphatases in most organisms. However, little attention has
been given to why these proteins in this family are so prevalent in nature. In the initial
chapter of this dissertation, attention is given to studies probing the stability of the core
domain as an evolutionary marker of the success of the HADs. To investigate this
stability, different subfamily proteins and commonalities between all HADSF (common
fold domains, and conserved residues) were explored with attention being given to
determining the domain dynamic associated with catalysis.
Both PPDK and HAD proteins utilize domain movement as part of their catalytic
mechanisms. In the HADSF small angle scattering was used to investigate key
interactions between domains and the factors that initiate movement of the domains and
how domain movement is connected to catalysis. Small angle scattering was used to
investigate the catalytically intriguing domain movement of PPDK in the solution phase.
Finally, neutron scattering structures of representative HADSF proteins were determined
13

and used to locate hydrogen interactions that lead to stability and catalytic activity. The
prevailing goal of this thesis work was to investigate using modern structural techniques
key evolutionary commonalities among members of protein super families that enable
them to have a unique prevalence.

14
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CHAPTER TWO
Case Study: HAD Subclass II Phosphatase, Mesorhizobium loti Dglycero-D-manno-Heptose-1,7-bisphosphate Phosphatase, Stability and
Structural Studies
2.1 Introduction
The HAD superfamily is one of the largest enzyme superfamilies, and it is the
major supplier of organophosphate metabolite phosphohydrolases (“phosphatases”) (4,
5). As described in Chapter 1, the focus of my doctoral research was to investigate
underlying reasons for the robustness and prevalence of the HAD superfamily. The
highly conserved catalytic domain (sometimes referred to as the “core domain”)
possesses a “Rossmann-like” fold (hereafter referred to as the Rossmann-fold). Based on
the findings from bioinformatic analysis it has been shown that the vast majority of the
family members also possess a cap domain which, as succinctly stated in the article by
Pandya et al (1) “leads to a natural classification of the superfamily into different
structural classes – C0 (no or minimal cap insert), C1 (α helical cap insert), C2 (α helical
and β strand cap insert, further sub-divided into C2a and C2b depending on topology)
and, C1+C2 (inserts in both positions), based on topology and location of the insert.”.
My goal was to examine the impact of domain insertion into the Rossmann-fold
core domain. As detailed in Chapter 1, the Rossmann-fold is one among only a handful of
known superfolds. We posited that the intrinsic stability and plasticity of the Rossmannfold made it possible for HAD superfamily core domain to accommodate the sequence
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inserts, which ultimately evolved to the cap domains of the C1 and C2 HAD family
members, which in turn lead to the explosive expansion of the HAD superfamily. The
fact that the cap domain insertions occur within the catalytic platform is remarkable and
at the same time, to be expected; “remarkable” because of the high potential for
disruption of catalysis, and “expected” because active sites are commonly formed by
loops which project from the structural framework of the enzyme (14).
In Burroughs et al (14-16) the authors divide the HAD superfamily into the type C0
proteins that have a core five-stranded -sheet, and the rest of the superfamily which
conserves the six-stranded -sheet. As detailed in Chapter 1, in order to carry out a sideby-side analysis of the core domain stability as a function of sequence insert size (loop vs
cap domain) we selected for study phosphatases from the six-stranded -sheet Rossmannfold core-domain division. The protein picked to represent the core domain having a
“extended-loop insert” at the C2 position, is D-glycero-D-manno-heptose-1,7bisphosphate phosphatase (GmhB). Determination of the structure-stability relationship
in GmhB is the focus of this chapter.
GmhB is a monomeric protein (2,3), which is ideal for structure-stability analysis.
Moreover, there are three GmhB orthologs (from E. coli, B. bronchiseptica and M. loti)
represented in the Protein Structure Data Base (PDB accession codes: 3L8H, 3L8E,
3L8F, 3L8G and 202X). In Figure 2.1, the structures of the three orthologs are compared.
Each possesses the family “squiggle motif” (colored purple), which positions the Asp
nucleophile and the Asp acid/base, and at the C2 insertion position an extended loop
(colored blue), which in E. coli and B. bronchiseptica binds a Zn2+ ion. An overlay of
three ortholog structures is shown in Figure 2.2, highlighting the three active site three
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loops (the Zn2+-binding loop-blue, loop 2-red and loop 1-green) which function in place
of a cap domain to bind the substrate-leaving group.

Figure 2.1: The GmhB orthologs from M. loti (left), E. coli (center), and B. bronchiseptia
(right) represented in the Protein Structure Data Base (PBD accession codes: 3L8H, 3L8E,
3L8F, 3L8G AND 2O2X).

A

B
Figure 2.2: (A) An overlay of three structures (PDB accession codes,
3L8G-red, 2O2X-blue, and 3L8H-green) is shown in Figure 2.2,
highlighting the collaboration between three loops (the Zn2+ binding
loop, loop2 and loop 1) in a productive binding and in desolvation of
the catalytic site. (B) shows represented loop as surface modeled on
PDB accession 2O2X.
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2.1.1 GmhB Function
GmhB catalysis is required in the S-layer glycoprotein and lipid A biosynthesis.
The GmhB substrate, the C(1) - or -anomer of D-glycero-D-manno-heptose-1,7bisphosphate, is formed as an intermediate in the D-glycero-D-manno-heptose-1-GDP
and L-glycero-D-manno-heptose-1-ADP pathways, respectively (see Figure 2.1). The
GmhB catalyzes the hydrolysis of the C(7)phosphate group of the D-glycero-D-mannoheptose-1,7-biphosphate C(1)  or -anomer to form D-glycero-D-manno-heptose-1phosphate or D-glycero-D-manno-heptose-1-phosphate, respectively (see Figure 2.3)
(2).

The

D-glycero-D-manno-heptose-1-phosphate

anomers

are

activated

by

nucleotidation for incorporation of the glycero-D-manno-heptose unit into the glycan of
the S-layer glycoprotein or lipid A.
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Figure 2.3: Chemical steps and enzyme catalysts of the A. thermoaerophilu D-glycero-Dmanno-heptose-1-GDP pathway and the E. coli L-glycero-D-manno-heptose-1-ADP
pathway.
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2.1.2 GmhB Active Site.
The active site of E. coli GmhB bound with the Mg2+ cofactor and the D-glycero-Dmanno-heptose-1,7-bisphosphate substrate is shown in Figure 2.4. The subject of the
structure-stability studies is M. loti GmhB, the X-ray structure of which was determined
for the apo enzyme (Figure 2.5). The residues that were mutated during the course of the
studies reported in this chapter are highlighted in the figure.

Figure 2.4: The active site of E. coli GmhB with Mg2+ cofactor (cyan sphere; water ligand
pink sphere) and the substrate D-glycero-D-manno-heptose-1b,7-bisphosphate bound (stick
with teal carbon atoms). Oxygen atoms are red, nitrogen atoms are blue and phosphorus atoms
are orange. Side chains are shown in stick with gray are yellow carbon atoms.
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Figure 2.5: The active site of M. loti GmhB (apo). Pink spheres represent water molecules
and dashed line represents hydrogen bonds. Residues in which the carbon atoms are colored
yellow were replaced by site-directed mutagenesis

2.2 Material and Methods
2.2.1 Materials
All restriction enzymes and T4 ligase were purchased from Invitrogen. Pfu Turbo
polymerase was purchased from Strategene. Oligonucleotides were custom synthesized
by Invitrogen. Components and buffer additives were all purchased from Sigma Aldrich
if not specified. DNA sequencing was performed by MC labs and MW mass
spectrometry determinations were carried out by UNM Mass Spec Facilities.

2.2.2 Cloning and Purification of M loti. GhmB
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The wild-type M. loti GmhB clone was obtained from PSI Materials Repository
(Clone ID: M1CD00090897). For purification, cell stock containing the plasmid
gmhB/pSPEED in BL21 (DE3) competent cells was used. M. loti GmhB was purified
using

a

modification

of

the

procedure

described

by

Wang

et

al.

(2).

GmhB/pSPEED/BL21 (DE3) cells were grown aerobically at 37 ºC in LB broth
containing 50 µg/mL kanamycin to an O.D600 of 0.5-0.7 and induced for production of
protein by adding 4 mM L-arabinose. Following a 12 h induction period at 18 ºC , cells
were harvested by centrifugation at 6,500 rpm for 10 min. Harvested cells were
resuspended in 10 x weight lysis buffer (50 mM HEPES, 200 mM NaCl, 50 mM
imidazole pH 7.5) and lysed using a Amico French press at 1,200 psi. the lysate was
centrifuged at 20,000 rpm for 20 min. Supernatant from centrifugation was loaded onto a
NTA-Ni HisTrap FF 5 mL column (GE Life Sciences) and the column was washed with
lysis buffer to remove unbound protein and the protein was eluted using elution buffer
(50 mM HEPES, 200 mM NaCl, 500 mM imidazole pH 7.5). Column fractions were
analyzed for protein using SDS-page gel electrophoresis. Fractions containing protein
were combined and dialyzed at 4 ºC against 3 changes 2L/2L/4L of 50 mM HEPES, 50
mM NaCl, and 5mM MgCl2 pH 7.2. Protein yield was ca. 20 mg/g wet cells.

2.2.3 Site-Directed Mutagenesis
Site-directed mutagenesis (SDM) was carried out using the Quick Change PCR
Strategy (Stratagene). Plasmids of WT/mutants were used as templates (mutant plasmid
as template in the event multiple mutations are desired) in PCR amplifications along with
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oligionucleotides, including mutated codon(s) as primer, and Pfu Turbo polymerase
(Strategene). Recombinant mutant plasmids transformed into BL21 (DE3) were
expressed initially on 10 mL culture scales. Cultures showing expression of protein were
verified using either gene sequencing or mass spectrometric analysis. All mutated
proteins were cultured and purified according to native protein protocol.

2.2.4 Determination of Steady-State Kinetic Constants
Phosphatase activities were determined using the EnzChek Assay (Invitrogen).
Reactions were monitored at 360 nm using a Shimadzu UV1800 UV/Vis spectrometer.
Reactions were carried out at 25 ºC in total volumes of 0.5 mL in 25 µL 20X buffer (1.0
M Tris-HCl, 20 mM MgCl2, pH 7.5), containing 100µL 2-amino-6-mercapto-7-methylpurine riboside (MESG), 5 µL purine nucleoside phosphorylase (PNP), and varying
concentration (0.5-5.0X Km) of phosphorylated substrates. Initial velocities, measured as
a function of substrate concentration, were analyzed using Enzyme Kinetics v1.4 and
equation 2.1, where V is the initial velocity, Vmax is maximum velocity, [S] is substrate
concentration, and Km is the Michaelis constant. The kcat values were calculated from
Vmax/[E] where [E] is the total enzyme concentration determined by uing the Bradford
method.
𝑉=

𝑉𝑚𝑎𝑥 [𝑆]
[𝑆]

+ 𝐾𝑚

2.2.5 Thermal Denaturation Monitored by Using Circular Dichroism
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eq. 2.1

GmhB was thermally denatured while using Circular Dichorism (CD) at
wavelength 222 nm to detect changes in secondary structure (12). Each assay solution
had a total volume of 0.6 mL and contained 0.1-0.2 mg/mL protein in buffer (10 mM
HEPES, 2.5 mM MgCl2 pH 7.1). The CD signal was recorded at 1 ºC step intervals from
20 ºC - 90 ºC (equilibration of temperature in between each step was made by incubation
for 30 s before). To determine the changes associated with complete denaturation, a full
wavelength CD scan between 260 and 215 nm was conducted before and after thermal
melting.
CD data were fitted to both a 2-state or 3-state denaturation model Table 2.1 (9).
SigmaPlot 11.0 was used to fit and normalize the data to the equation shown in eq. 2.2,
where y is the measured molar ellipticity (fU for normalized graph), yo is the smallest
molar ellipticity (fU for normalized graph), a is Δy, x is Temperature, xo (Tm) is the
temperature at one-half a, and b is the slope associated with the transition from folded to
unfolded forms.

𝑦 = 𝑦𝑜 +

𝑎
1+𝑒
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𝑥−𝑥𝑜
−(
)
𝑏

eq. 2.2

Description

2-state model
𝑲𝒆𝒒

𝑵 → 𝑼
Equilibrium constant and total protein
concentration

𝐾 =

[𝑈]
[𝑁]

𝑃𝑇 = [𝑁] + [𝑈]

3-state model
𝑲𝟏

𝑲𝟐

𝑵↔ 𝑰 ↔ 𝑼
𝐾1 =

[𝐼]
[𝑈]
𝐾2 =
[𝑁]
[𝐼]

𝑃𝑇 = [𝑁] + [𝐼] + [𝑈]

Definition of molar fraction fN

1
1+𝐾

1
1 + 𝐾1 + 𝐾1 𝐾2

Definition of molar fraction fI

---

𝐾1
1 + 𝐾1 + 𝐾1 𝐾2

Definition of molar fraction fU

𝐾
1+𝐾

𝐾1 𝐾2
1 + 𝐾1 + 𝐾1 𝐾2

𝑌 = 𝑌𝑁 𝑓𝑁 + 𝑌𝑈 𝑓𝑈

𝑌 = 𝑌𝑁 𝑓𝑁 + 𝑌𝐼 𝑓𝐼 + 𝑌𝑈 𝑓𝑈

Fitting equation

Table 2.1: Equilibrium-folding models for monomeric proteins. N represents native folded
protein, U represents unfolded proteins, I represents intermediate folded protein, [N]
represents concentration of native protein, [I] represents concentration of intermediate, [U]
represents concentration of unfolded protein, PT is total protein concentration, K represents
equilibrium for each transition, Y represents fitting equation for respective model.

2.2.6 Chemical Denaturation Monitored by Using Circular Dichroism
Chemical denaturation of proteins was carried out while being monitored with an
Aviv model 420 Circular Dichroism at wavelengths 217, 222 nm. All samples consisted
of protein (ca. 0.1-0.15 mg/mL), buffer (10 mM HEPES, 2.5 mM MgCl2 pH 7.1), and
urea (concentrations between 0.0 -7.0 M) at a total volume of 0.6 mL. Each sample was
incubated at specified denaturant concentration for 10 min at room temperature to ensure
equilibrium is attained. CD data were collected at specified wavelengths in triplicate with
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a 5 second averaging time. To ensure complete unfolding occurred, the protein was tested
for catalytic activity and full scans between 215 - 260 nm were recorded on samples
treated with 0.0 and 8.0 M denaturant. The data were fit to a 2-state or 3-state model as
described above and used to calculate Gibbs Free Energy (ΔG) using the extrapolation
method (10,11).

2.2.7 Chemical Denaturation Monitored by Using Small Angle Scattering
Tryptophan fluorescence and Circular Dichroism probe the respective changes
taking place in the amino acid environment and secondary structure of proteins. In order
explore changes occurring in the tertiary structures of proteins, denaturation was
monitored by using Small Angle X ray Scattering (SAXS) and the Stanford Synchrotron
Radiation Lightsource on the 4-2 bio-SAXS beamline. Protein samples ranged from 3-10
mg/mL in 50 mM HEPES, 5 mM MgCl2, 75 mM NaCl, pH 7.2, containing varying
amounts of denaturant (urea, 0.0 - 7.0 M). The Rg values associated with SAXS for
proteins were used as an indicator of changes in conformation caused by changes in the
denaturant concentration. To determine Rg, data for the protein samples and
corresponding buffer samples were collected and processed using the ATSAS program
package (PRIMUS) (13). Values used to interpret the results (ΔG, m, deq) were calculated
in the same manner as described handling CD or fluorescence data arising from chemical
denaturation.

2.3 Results and Discussion
35

2.3.1 Chemical Denature of Native M. loti GmhB Unfolds According to a 3-State
Model
M. loti GmhB was denatured using urea and monitored using three different
techniques that investigate different aspects of the protein structure. Fluorescence was
used to track the tryptophan environment and changes to its surroundings (emission 285
nm, excitation ~340 nm). To investigate the secondary structure of the protein, CD was
used (molar ellipticity was monitored at 222 nm). Lastly to track the tertiary structure of
the protein small angle X ray scattering (SAXS) was used (monitored the change in dmax).
Table 2.1 tabulates the denaturant constants from denaturant experiments using urea.
Figure 2.6 visually describes the difference between deq of the three denaturant curves.
The calculated Gibbs Free Energy of GmhB was ~-4824.00 ± 239.00 in
dependent of detection technique. This amount in modest compared to some similar
structures tested (6). This value tells us that the Rossmann-like HAD core domain is
stable,
Observing the protein denature using different techniques allow further
interpretation into the denaturing model. From Figure 2.6 we see that the denature curves
show different transition regions (deq); this signifies the protein follows a more complex
model that a simple 2-state model. A 3-state model was used to interpret the data, Figure
2.7. Interestingly the tertiary structure is modified, whereas the secondary structure is
intact until the second transition. From this data we can imagine the protein losses the
compact tertiary structure near ~2.0 M urea and the rest of the fold is lost near 3.5 M
urea.
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M. loti GmhB is a reasonable starting point to investigate the fold stability of the
HAD core domain. GmhB is a capless monomer protein that unfolds through a threestate model such that the protein tertiary structure is lost and an intermediate structure is
short lived before all structure is lost. This could be explained with the tertiary structure
of the core domain; the topology map, Figure 2.8, shows a possible scenario in which the
core domain consist of two sub-domains that are held together using intramolecular
interactions. The loss of tertiary structure but not secondary structure can be explained
through the dis-association of the sub-domains.

Technique

Gibbs Free Energy (cal*mol-1)

m (cal*mol-1*M-1)

deq (M)

Fluorescence

-4594.9

1315.00

3.49

Circular Dichroism

-4804.7

1432.20

3.28

Small angle scattering

-5072.8

2445.10

2.07

Table 2.1: Table includes calculated constants from chemical denature. All reactions were
carried out in buffer containing (20 mM HEPES, 2.5 mM MgCl2 pH 7.2). Urea concentration
was carried out every 0.25 M from 0.0 – 7.0.
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Figure 2.6: Normalized denature plot of native M. loti GmhB. Chemical denature was
performed using urea as chaotrope. BLACK: native GmhB observed using Fluorescence,
RED: native GmhB observed using Circular Dichroism, and GREEN: native GmhB observed
using SAXS.
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Figure 2.7: Chemical denature plots were fit separately to a 2-state model, but because the
denature data observed with different techniques do not overlap suggests a more complex
model. BLACK lines represent the two chemical denature plots fit to a 2-state model whereas
colored lines represent fitting to a 3-state model with variation in amount of intermediate
structure, each line is an increment of 10% intermediate (molar fraction).

38

Figure 2.8: Protein topology map of M. loti GmhB. RED dashed line suggests interacting
surfaces between sub-domains in GmhB. The loop from residue 118-136 is the only
connecting sections between the two sub-domains.

2.3.2 Mg2+ Cofactor Show Minimal Effect on Protein Stability
In HAD proteins the active site consists of 5 conserved motif throughout all subclasses. Also conserved is the use of Mg2+ cofactor which is bound by catalytic aspartates
and interaction with a backbone carbonyl group. Previous studies have shown that
activity is abolished without Mg2+ (7), experiments on activity of GmhB in the absence of
cofactor support previous studies (data not shown), but what affect does the cofactor have
on structure and stability? GmhB without Mg2+ was tested for changes in stability similar
to native experiments with the exception of no Mg2+ in buffer.
Data collected from thermal and chemical denature experiments show similar
thermal stability, but a decrease in Gibbs Free Energy from chemical denature
calculations. Table 2.2 displays changes in biophysical calculated constants. As shown
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the thermal stability based on Tm show very similar values 49.83 ± 0.06 and 50.80 ± 0.10
for +Mg2+ and ΔMg2+ respectively. Chemical denature of GmhB presents the protein as
less stable when cofactor is not present (Table 2.2 and Figure 2.9). Although the deq for
the two samples are essentially the same the deciding factor to the minimized stability is
the slope associated with the samples. The slope, m, has been correlated to the accessible
surface are to solvent during unfolding (9). Chemical denature of the native protein has
illustrated a possible scenario in which the protein consists of two sub-domains held
together through intramolecular interactions. This scenario can be supported by the
chemical denature data collected on the protein without Mg2+ cofactor. From crystal
structures we can see that the cofactor is bound near the interacting area of the two "subdomains", and when the cofactor is not present we see larger accessible surface area due
to an increase in m-value which would express a loss of possible favorable interactions
that keep the sub-domains together.

Protein

Tm (ºC)

Gibbs Free Energy

m (cal*mol-1*M-1)

deq (M)

(cal-1 mol-1)
WT with Mg2+

49.83 ± 0.06

-4804.7

-1432.2

3.35

WT Δ Mg2+

50.80 ± 0.10

-3088.0

-942.55

3.28

Table 2.2: Table includes calculated constants from chemical denature. Reactions including
Mg2+ were carried out in buffer containing (10 mM HEPES, 2.5 mM MgCl2 pH 7.1).
Reactions without Mg2+ were carried out in buffer including (10 mM HEPES, 5 mM NaCl pH
7.1). Urea concentration was carried out every 0.25 M from 0.0 – 7.0.

40

1.0
0.8

fu

0.6
0.4
0.2
0.0
0

2

4

6

Urea [M]
Figure 2.9: Normalized denature plot of native M. loti GmhB with/without Mg2+. Data was
observed using Fluorescence. BLACK: M. loti GmhB with Mg2+, and RED: M. loti GmhB
without Mg2+.

2.3.3Active Site Residues Play Unique Roles in Protein Stability
Engineered point mutations in protein chemistry have been widely used to
experimentally investigate protein evolution. Protein activity is closely tied to protein
structure and due to the intricate interactions that make a functional protein (tertiary
structure). In many cases charged residues are positioned within the active site, this
phenomenon gave rise to the theory of fold/function trade-off. This suggests that because
the necessity of charge residues near substrate for activity the stability is compromised
due unfavorable interactions between similarly charged residues. To test the idea that
active site activity is traded for fold stability we created point mutations of conserved
active site residues. Conserved motifs were mutated to alanine and tested for activity and
stability.
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Phosphatase activity is driven by nucleophilic catalysis including motif 1 (DXD).
The first sets of point mutations were D36A and D38A (DXD). In both cases the protein
is inactive. Table 2.3 display calculated values from chemical and thermal denature.
Results show distinct changes in stability between the two aspartate mutants.
The D36A mutation shows a small decrease in stability when compared to native
values, but not drastic when compared to changes due to the D38A mutation. The D38A
mutation shows a substantial change in stability, both thermal and chemical stability.
Although both residues are necessary for catalysis they affect protein stability differently.
For completeness the third coordinating (interaction with cofactor Mg2+) aspartate was
mutated to alanine. From stability tests the protein showed to be as stable as the native
protein suggesting no effect on fold stability.
It could be possible that changes in the active site (i.e., point mutations) can affect
and possibly drive changes in surrounding residues. To test the possible additive or
deleterious effects on protein stability due to single mutations of active site residues, both
a double and triple mutant were created (D36A/D38A and D36A/D38A/D161A
respectively).
The constructed multi-point mutation proteins performed similar to the D38A
GmhB, both chemically and thermally the two proteins were destabilized. The possible
rescue of stability by creating the multi-mutants was not observed, even though the
decrease in charge repulsion due to multiple aspartates was created. Although the
stability was not rescued from the D38A mutation, there was also no decrease in stability
due to the additional point mutations.
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HAD activity is derived from the conserved DXD motif. The two aspartates play
different roles in the catalysis of substrates, but nucleophilic attack is promoted by the
first aspartate of the conserve sequence, followed by the acid/base regeneration of the
protein. From our results we see that although Asp36 is necessary for catalysis it has no
effect on stability when changed. On the other hand the Asp38 shows effect on both
activity but most intriguing is the effect on stability. Asp38 shows to destabilize the
protein when absent which suggests an evolved necessity for not only activity but
stability which could possibly refute the fold/ function trade-off.

Protein

Tm (ºC)

Gibbs Free Energy

m (cal*mol-1*M-1)

deq (M)

(cal-1 mol-1)
WT

49.83 ± 0.06

-4804.7

-1432.2

3.35

D36A

48.99 ± 0.05

-4181.1

-1328.9

3.15

D38A

38.04 ± 0.14

-1603.0

-839.2

1.91

D161A

49.38 ± 0.09

-3937.7

-1203.6

3.27

D36A/D38A

40.12 ± 0.18

-1609.4

-874.3

1.84

D36A/D38A/D161A

37.35 ± 0.11

-1284.8

-792.4

1.62

Table 2.3: Table includes calculated constants from chemical denature. All reactions (both
chemical and thermal denature) are carried out in following reaction buffer (20 mM HEPES,
2.5 mM MgCl2 pH 7.2).
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Figure 2.10: Thermal Denature of M. loti GmhB DxD mutants. MAGENTA:
D36A/D38A/D161A GmhB, GREEN: D38A GmhB, BLUE; D36A/D38A GmhB, TEAL:
D161A GmhB, RED: D36A GmhB, and BLACK: native GmhB

2.3.4 Conserved HAD Motifs and Pin Residues
As in every fold family there are many residues conserved throughout members of
each family. In the HAD superfamily there are also other motifs conserved along with the
acitve site DXD squiggle. For completeness, the other conserved motifs were tested for
stabilty when mutated to alanine. The other conserved motifs include motif II: a
conserved theronine/serine, motif III is centered around a conserved lysine. Motif IV is
associated with a series of amino acids exhibiting one of three signatures: DD, GDxxxD,
or GDxxxxD. The acidic residues are required for coordinating the Mg2+ cofactor.
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Protein

Tm (ºC)

Gibbs Free Energy

m (cal*mol-1*M-1)

deq (M)

(cal* mol-1)
WT

49.83 ± 0.06

-4804.7

-1432.2

3.35

T78A

41.86 ± 0.11

-1851.0

-889.42

2.08

K136A

49.04 ± 0.10

-

-

N42A

---

---

---

-1848.7

-930.24

N42A/K136A

1.99

Table 2.4: Calculated stability variable for conserved HAD residues. All samples contained 20
mM HEPES, 2.5 MgCl2 pH 7.2.

Motif IV residue Asp161 has been evaluated previously,in Table 2.4. The
calculatated value for the other conserved motifs are presented. From collected data we
see that the Thr78 plays a part in protein stability with a decrease in stability based on Tm
and ΔG of 41.86 ± 0.11 ºC and -1851.0 cal*mol-1 respectively. Motif III Lys136 showed
no particular change in stability (Tm) when compared to native GmhB.
Thr78 from crystal structure (PDB: 2O2X) is within H-bonding distance to amine
group of Asn80 side chain, but also in vicinity of the Asn80 is active site residue Asp38
(from previous studies is showed to be key in stability). From the H-binding network
created by solvent and residue side chains it could be possible that the T78A mutant
disrupts the bonding network connected to Asp38 in which causes a destabilization
similar to the D38A mutant.
Lys136 has been conserved and shown to bind and stabilize the phosphoryl group
on the bound substrate. The lysine shows thermal stability (Tm) similar to native protein,
~0.8 °C which suggests a small to no effect on the stability.
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Asparagine 42 has been shown to interact through H-bonding with Asp 38, Figure
2.11. To test if the stability of the structure is altered by the loss of bonding between the
two residues the mutant was attempted. Unfortunately the point mutation Asn42 could
not be produced, although the double mutant N42A/K136A was created. As previously
observed the K136A mutant showed no effect on stability whereas the double mutant
shows a decrease in stability (ΔG). From the collective of data between the single mutant
and double mutant we can suspect that the decrease in stability is due to the Asn42 rather
than the Lys136 although we cannot overlook the possibility that the decrease is an
additive effect of the two point mutations.

Asp38
Asn42

Asp36

Figure 2.11: Ribbon diagram from M .loti GmhB (PDB 2O2X) displaying the interaction of
Asp38 and pin residue Asn42.

The HAD superfamily has shown to be a prominent staple in phosphatase activity.
The construct of the structure has allowed the protein to separate catalysis and substrate
recognition through separating phosphoryl binding and metabolite binding. The
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conserved residues are notably associated with the phosphate binding and the active site.
From our stability studies we have observed some conserved residues that play a role in
not only activity but stability (Asp38, Thr78), whereas other conserved motifs play small
to no role in stability (Lys136, Asp36, and Asp161). The pin residues when mutated in
accompany with K136A shows a noticeable decrease in stability similar to D38A. This
decrease cannot be tracked to the Asn mutation without knowing the affect due to the
single point mutation, but when compared to other residues that interact with D38A
(T78A) we do in fact see a decrease in stability which supports the idea that Asn42 plays
a role in the stability of the protein.

2.3.5 Effect of Side Chain on Active Site Stability
It is customary to mutate active site residues to homologous amino acids for Xray crystallography to mimic ligand binding without proceeding through reduction of
substrate to product. For this reason three mutants were created to investigate the effects
on stability due to changes inside chain residues at the second aspartate in the DXD
motif. The aspartic acid was mutated to glutamic acid, asparagine and previously
mentioned alanine. Table 2.5 and Figure 2.12 show that changes in stability constants
when mutations were tested. When changed to alanine the interaction of D38A is lost
between it and the pin residue
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Gibbs Free Energy (cal-1 mol-1)

m (M*cal*mol-1)

deq (M)

49.8 ± 0.1

-4804.7

1432.2

3.35

D38A

38.0 ± 0.1

---

---

---

D38E

41.7 ± 0.2

---

---

---

D38N

46.6 ± 0.4

---

---

---

Protein

Tm (ºC)

WT

Table 2.5: Calculated stability variables for point mutation variations at residue Asp38.
Thermal denature buffer was 20 mM HEPES, 2.5 MgCl2, pH 7.2. Sample concentration ~0.1
mg/mL.
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Figure 2.12: Thermal Denature of GmhB with different amino acids at Asp38. Black: Native,
RED: D38A, BLUE: D38N, and GREEN: D38G

2.4 Conclusion
Mesorhizobium loti D-glycero-D-manno-Heptose-1,7-bisphosphate Phosphatase,
GmhB is a subclass 0 HAD protein. The protein catalyzes the dephosphorylation of Dglycero-D-manno-heptose 1,7-biphosphate. Because of the prior knowledge about GmhB
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(bioinformatics, structure, etc.) (1-3) it is natural to use GmhB as a starting point in
investigating the stability of the HAD proteins. The overarching goal is to identify
possible reasons for the prominences and reliability of HAD members used as a majority
of phosphatases in organisms.
Results collected from GmhB studies have identified possible trends in stability
based on the structure of the protein especially the active site residues. We have shown
that GmhB unfolds through a 3-state unfolding model with a complete loss of tertiary
structure before the loss of secondary structure. The relative stability of the protein is
modest when compared to similar sized proteins (6). Conserved residues shows either no
change to structural stability whereas a select few decreased the stability base on both T m
and ΔG; residues associated with Asp38 (bonding networks or H-bonding directly) show
similar decrease as the D38A point mutation.
A majority of HAD proteins incorporate large sub-domains to help increase
binding to native substrate. To better understand the structural stability of the HAD
family a model of stability for the conserved active site domain (core domain) needs to be
established. GmhB has been shown through bioinformatics to be a capable model for the
standard core domain.

49

References
1. Pandya, C., S. Brown, et al. (2013). "Consequences of domain insertion on sequencestructure divergence in a superfold." Proceedings of the National Academy of
Sciences 110(36): E3381-E3387.

2. Wang, L., H. Huang, et al. (2010). "Divergence of Biochemical Function in the HAD
Superfamily: d-glycero-d-manno-Heptose-1,7-bisphosphate Phosphatase (GmhB)."
Biochemistry 49(6): 1072-1081.

3. Nguyen, H. H., L. Wang, et al. (2010). "Structural Determinants of Substrate
Recognition in the HAD Superfamily Member d-glycero-d-manno-Heptose-1,7bisphosphate Phosphatase (GmhB)." Biochemistry 49(6): 1082-1092.

4. Collet, J. F., van Schaftingen, E., and Stroobant, V. (1998) A new family of
phosphotransferases related to P-type ATPases. Trends Biochem. Sci. 23, 284.

5. Koonin, E. V., and Tatusov, R. L. (1994) Computer Analysis of Bacterial Haloacid
Dehalogenases Defines a Large Superfamily of Hydrolases with Diverse Specificity:
Application of an Iterative

50

6. Filimonov, V. V., J. Prieto, et al. (1993). "Thermodynamic analysis of the
chemotactic protein from Escherichia coli, CheY." Biochemistry 32(47): 1290612921.

7. Lu, Z., D. Dunaway-Mariano, et al. (2005). "HAD Superfamily Phosphotransferase
Substrate Diversification: Structure and Function Analysis of HAD Subclass IIB
Sugar Phosphatase BT4131†,‡." Biochemistry 44(24): 8684-8696

8. Myers, J. K., C. Nick Pace, et al. (1995). "Denaturant m values and heat capacity
changes: Relation to changes in accessible surface areas of protein unfolding."
Protein Science 4(10): 2138-2148.

9. Jad Walters, Sara L. Milam, A. Clay Clark, Chapter 1 Practical Approaches to Protein
Folding and Assembly: Spectroscopic Strategies in Thermodynamics and Kinetics,
In: Michael L. Johnson, Jo M. Holt and Gary K. Ackers, Editor(s), Methods in
Enzymology, Academic Press, 2009, Volume 455, Pages 1-39,

10. Pace CN. Determination and analysis of urea and guanidine hydrochloride
denaturation curves. Methods Enzymol.1986;131:266–280.

51

11. Greene RFJ, Pace CN. Urea and guanidine hydrochloride denaturation of
ribonuclease, lysozyme, alpha-chymotrypsin, and beta-lactoglobulin. J Biol
Chem. 1974;249:5388–5393.

12. Provencher, S. W., & Gloeckner, J. (1981). Estimation of globular protein secondary
structure from circular dichroism. Biochemistry, 20(1), 33-37.

13. Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H., & Svergun, D. I.
(2003). PRIMUS: a Windows PC-based system for small-angle scattering data
analysis. Journal of Applied Crystallography, 36(5), 1277-1282.

14. Burroughs, A. M., Allen, K. N., Dunaway-Mariano, D., & Aravind, L. (2006).
Evolutionary genomics of the HAD superfamily: understanding the structural
adaptations and catalytic diversity in a superfamily of phosphoesterases and allied
enzymes. Journal of molecular biology, 361(5), 1003-1034.

15. Allen, K. N., & Dunaway-Mariano, D. (2004). Phosphoryl group transfer: evolution
of a catalytic scaffold. Trends in biochemical sciences, 29(9), 495-503.

52

16. Allen, K. N. and D. Dunaway-Mariano (2009). "Markers of fitness in a successful
enzyme superfamily." Current Opinion in Structural Biology 19(6): 658-665.

53

CHAPTER THREE
Case Study: Stability of HAD Subtype II Phosphatase YbiV
3.1 Introduction
Escherichia coli K12 YbiV is a sugar phosphatase belonging to the Haloacid
Dehalogenase Superfamily (HAD). The function in E. coli has not yet been discovered.
From substrate screening and bioinformatics the protein is regarded as a sugar
phosphatase that prefers ribose-5-phosphate and slightly less glucose-6-phopshate (1). It
is hypothesized that the protein could be associated with regulation and recycling of
molecules in the cell or possibly included in stress induced production of metabolites
similar to trehalose production (2).
YbiV belongs to the subclass II of the HAD family. Characteristic of HAD
proteins is a core Rossmann-like domain housing conserved active site residues directing
phosphate binding. The subclass is defined by a / domain insert between motif II and
III. Because the core domain binds the phosphate group for dephosphorylation, the
superfamily has evolved inserts to increase binding affinity to substrates. The large /
domain insert of the subclass II family has been shown to help bind alcohol leaving group
of substrate (1, 3-5).
In previous chapters we looked at the fold-fitness of GmhB, a C2 protein, is a
"capless" HAD protein that will be used as a model for stability of the core domain of
HAD proteins. In the HAD family, the majority of HAD proteins include a cap insert
responsible for substrate binding. How do these large insert affect the stability of the core
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domain? To explore the effect of domain inserts on the stability of the HAD proteins we
will characterize YbiV in terms of fold fitness and robustness. Because previous stability
studies have uncovered possible trends in the HAD family we will look into the stability
of the protein in terms of Mg2+ binding, conserved active site residues and active site
bonding networks Figure 3.1 . In order to determine the most complete picture possible a
multitude of techniques will be applied.
Because proteins fold in complex structures through secondary interactions as
well and complex systems; denature studies will include 3 techniques (fluorescence,
circular dichroism, and small angle X ray scattering) to investigate the change in
conformation of different ordered structures (1º, 2º, and 3º respectively). All denature
data will be fit to either a 2-state or 3-state model.

Asn46
Lys19

Lys192
Lys19
Asp215
Asp11
Asp9

Figure 3.1: X-ray crystal of YbiV (PDB: 1RLO) with residues colored in yellow in which
were mutated to investigate change in stability.

55

3.2 Material and Methods
3.2.1 Materials
All restriction enzymes and T4 ligase were purchased from Invitrogen. Pfu Turbo
polymerase was purchased from Stratagene. Oligonucleotides were custom-synthesized
from Invitrogen. Components and buffer additives were all purchased from Sigma
Aldrich if not specified. To verify correct sequence, DNA sequencing was performed by
MC labs and MW mass spec determination was carried out by UNM Mass Spec
Facilities.

3.2.2 Cloning and Purification of E. coli YbiV
The wild-type YbiV protein was cloned using PCR amplification from K-12
strain E. coli (ATCC). PCR experiment used K-12 E. coli as a template with custom
oligonucleotides incorporating restriction sites for future ligation into vector, Pfu Turbo
polymerase (Stratagene) was used for amplification. The forward primer included a NheI
restriction site whereas the reverse primer included a XhoI restriction site. The amplified
PCR product was digested with previously mentioned restriction enzymes and ligated
into digested vector pET-28a (Novagen) using T4 ligase (NEB). The cloned genes were
transformed into BL21* (DE3) competent cells (Invitrogen). Colonies were tested for
expression and verified by gene sequencing upon expression.
YbiV/pET-28a/BL21 (DE3) cells were grown aerobically at 37 ºC containing 50
µg/mL kanamycin in LB broth to an O.D600 0.6-0.9 and induced for production of protein
by adding 0.4 mM isopropyl--D-galactopyranoside (IPTG). Following a 12 hour
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induction period at 18 ºC, cells were harvested by centrifugation at 6,500 rpm for 10
minutes. Harvested cells were resuspended in 10x w/v lysis buffer (50 mM HEPES, 200
mM NaCl, 50 mM imidazole pH 7.5). Resuspended cells were lysed using a Amico
French press at 1,200 psi, lysate was centrifuged at 20,000 rpm for 20 minutes.
Supernatant from centrifugation was loaded onto a NTA-Ni HisTrap FF 5 mL column
(GE Life Sciences). Column was washed with lysis buffer to clean any un-bound protein
and bound protein was eluted using elution buffer (50 mM HEPES, 200 mM NaCl, 500
mM imidazole pH 7.5). Column fractions were tested for clean protein using SDS-page
gel; all fractions containing clean protein samples were combined and dialyzed at 4 ºC
against 3 rounds ,2L/2L/4L, of 50 mM HEPES, 50 mM NaCl, 5mM MgCl2 pH 7.2.
Protein yield was ~15 mg/g wet cells.

3.2.3 Site-Directed Mutagenesis
Site directed Mutagenesis was carried out using the Quick Change PCR Strategy
(Stratagene). WT/mutants plasmid were used as template (mutant plasmid as template in
the event multiple mutations are desired) in PCR amplification, oligionucleotides
including mutated codon as primer, and Pfu Turbo polymerase (Stratagene).
Recombinant mutant plasmids were transformed into BL21 (DE3) and tested in small
scale cultures for expression. Cultures showing expression of protein were verified using
either gene sequencing or mass Spec. All mutated proteins were cultured and purified
according to wild-type (WT) protocols.
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3.2.4 Mg2+ Chelatating Protocol
To investigate the changes in stability due to the absence of Mg2+ cofactor the
protein needs to be purified and cofactor chelated from sample. M. loti GmhB was
purified similar to native protocol with the following exceptions: After elution of protein
from NTA-Ni column, sample is equilibrated with 15 mM EDTA. Protein sample is
incubated for 30 minutes on ice with occasional disruption. Protein/EDTA solution was
dialyzed against buffer excluding Mg2+, buffer was chelexed against BioRad Chelex ®
100 resin, (25 mM HEPES, 50 mM NaCl, pH 7.2. Three rounds of dialysis was carried
out to ensure absolute loss of Mg 2+.

3.2.5 Determination of Steady-State Kinetic Constants
The Kcat and Km values for native and mutant YbiV and substrate ribose-5phosphate were determined as described in Chapter 2.

3.2.6 Thermal Denature Using Circular Dichroism
Circular dichroism was used to observe the secondary structure of YbiV as a
function of temperature. Procedures and fitting models are described in Chapter 2.

3.2.7 Chemical Denature of Ordered Protein Structure
Three techniques were used to investigate the ordered structure of YbiV.
Tryptophan fluorescence was used to investigate the aromatic (mainly tryptophan)
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surroundings and local polarity. To observe changes in the secondary structure of the
protein circular dichroism was used at wavelengths 222 and 217 nm. For the tertiary
structure small angle scattering was implemented; SAXS was used to generate a
calculated solution volume in which was used to identify the general shape of the solution
conformation of the protein. Procedures and fitting models for chemical denature
experiments are discussed previously in Chapter 2.

3.3 Results and Discussions
3.3.1 Native E. coli YbiV Stability
Fold-fitness of the native YbiV protein was experimentally observed using
chemical and thermal denature techniques. Thermal denature monitored only changes in
secondary structures whereas chemical denature occurred using three detection
techniques to ensure the correct unfolding model was used. Table 3.1 displays variables
used to rate protein stability.
Results from denature experiments describe the protein to be very stable with an
average ΔG of 10.839 kcal*mol-1 and Tm ~55.1 ºC. The stability when compared to M.
loti GmhB is significantly higher; this result suggests that the protein is more stable when
the cap domain is present. Similar to the M. loti GmhB, According to data collected from
tryptophan fluorescence and circular dichroism YbiV folds through a 2-state model,
Figures 3.2-3.8. Because the normalized data overlay between the two techniques we
assume the protein unfolds from native to denatured without the presence of an
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intermediate structure. Data was collected with a third detection technique to observe the
loss of tertiary structure.

Technique

ΔG (cal*mol-1)

m (cal*mol-1*M-1)

deq (M)

Fluorescence

-8207.7

-1808.8

4.53

Circular Dichroism (CD)

-5685.4

-1327.8

4.28

Small angle X ray scattering (SAXS)

-18626

-5162.8

3.60

-4
-6

2

Molar Elipticity [deg cm dmol

-1

Table 3.1: Comparison of stability variable of native E. coli YbiV using different detection
techniques. Buffer in all experiments was 20 mM HEPES, 2.5 mM MgCl2+ pH 7.20 with
increasing urea concentration. protein concentration was ~10 µM in all experiments.
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Figure 3.2: Four chemical denature sets were collected for YbiV using CD. Standard
deviation from average is shown for CD detection at 222 nm. Buffer: 20 mM HEPES, 2.5
mM MgCl2+ pH 7.20 with increasing urea concentration. Protein concentration was 0.1
mg/mL.
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Figure 3.3: Fit line with averaged CD data for chemical denature of YbiV. Fit is a 4-parameter
sigmoidal fit with variables: a= 11.8014, b= 0.3879, x0= 4.3157, and yo= -17.9573
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Figure 3.4: Normalized fit of chemical denature data using CD.
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Figure 3.5: Four chemical denature sets were collected for YbiV using tryptophan
fluorescence. Standard deviation from average is shown for fluorescence detection at
excitations: 280 and 285 nm, emission: 340 and 352 nm. Buffer: 20 mM HEPES, 2.5 mM
MgCl2+ pH 7.20 with increasing urea concentration. Protein concentration was ~2-5 µM.
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Figure 3.6: Fit line with averaged tryptophan fluorescence data for chemical denature of
YbiV. Fit is a 4-parameter sigmoidal fit with variables: a= 2823502, b= -0.3876, x0= 4.2624,
and yo= 4038595.
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Figure 3.7: Normalized fit according to a 4-parameter fit of chemical denature of YbiV using
tryptophan fluorescence. Excitation: 280, 285 nm and emission: 340 and 352 nm.
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Figure 3.8: Chemical denature of YbiV using 2 different techniques to investigate correct
fitting model of denature data. BLACK: circular Dichroism and RED: Fluorescence.
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Small angle X-ray scattering data was collected to observe changes in tertiary
structure as a function of urea. From the previous chemical denature data sets we can see
that the data overlap which suggest a 2-state unfolding model, but with the incorporation
of SAXS data Figure 3.9-3.15 we can see YbiV possibly unfolds through a 3-state model
(due to absence of overlap of titration data from the three techniques.
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Figure 3.9: Fit line with small angle X ray scattering data for chemical denature of YbiV. Fit
is a 4-parameter sigmoidal fit with variables: a= 30.5510, b= 0.1050, x0= 3.6083, and yo=
22.9548. Rg was calculated for each [urea] using PRIMUS.
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Figure 3.10: Normalized fit according to a 4-parameter fit of chemical denature of YbiV using
SAXS.
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Figure 3.11: Chemical denature of YbiV using three detection techniques. GREEN: SAXS,
RED: fluorescence, and BLACK: circular dichroism.
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From Figure 3.11 we can see the SAXS data does not overlap with the other two
techniques suggesting the protein unfolds according to a 3-state model. With further
investigation into collected denature data from both fluorescence and CD (particularly
fluorescence) Figure 3.2 and 3.5; we can see a possible accumulation of intermediate near
3.75 M urea. This possible accumulation of intermediate is near 0.2 molar fraction
unfolded protein. Figure 3.12 represents a universal fit to SAXS data and overlaid
CD/fluorescence and describes possible intermediate fraction 0.2 (6). Data collected
favor a stable 3-state model of unfolding for YbiV.
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Figure 3.12: Normalized fit of chemical denature of YbiV compared to calculated 3-state
model. BLACK: SAXS detection technique, GREEN: CD detection technique, and RED:
calculated denature plot with a 0.2 molar fraction intermediate.

3.3.2 Effect of Mg2+ Cofactor on Stability
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Conserved among HAD proteins is the Mg2+ cofactor, it is well known that it is
necessary for catalysis. How does it affect the structure strength of the subclass II HAD
protein? Cofactor was chelated according to previously mentioned methods, and tested
similar to native protein for structure stability.
Thermal and chemical stability results Table 3.2 we can see that Mg2+ plays an
import roll in strength of the structure. From the collected data, results show two distinct
denature paths, Figures 3.2-3.4, 3.13-3.16 display the two chemical denature data sets.
From denature of native YbiV we know that it unfolds according to a 3-state model
although the intermediate is not present in the sample without Mg2+ does not necessarily
mean it does not exist. Stability is decrease in the absence of cofactor suggesting a role in
structure stability. Evan though thermal denature alone cannot determine if an
intermediate is sampled during the unfolding process, it is a good marker for stability
changes among same protein. Thermal denature of YbiV with and without Mg2+ display
similar trends in stability (Tm) as ΔG between the two proteins Figure 3.17-3.21.

Protein

Tm (ºC)

ΔG (cal* mol-1)

m (cal*mol-1*M-1)

deq (M)

WT with Mg2+

55.4 ± 0.1

-5685.4

-1327.8

4.28

WT without Mg2+ 50.2 ± 0.1

-5033.2

-1535.3

3.28

Table 3.2: Comparison of stability variables of WT E. coli YbiV with and without cofactor,
Mg2+. Protein buffers were made to have similar charge stabilization effects from added ions
without the addition of Mg2+. Protein buffer for native included 20 mM HEPES, 2.5 mM
MgCl2+, pH 7.20, whereas protein buffer for ΔMg2+ included 20 mM HEPES, 5 mM NaCl,
pH 7.20.
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Figure 3.13: Four chemical denature sets were collected for YbiV ΔMg2+ using CD. Standard
deviation from average is shown for CD at 222 nm. Buffer: 20 mM HEPES, 5.0 mM NaCl pH
7.20 with increasing urea concentration. Protein concentration was ~0.1 mg/mL.
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Figure 3.14: Fit line with averaged CD data for chemical denature of YbiV ΔMg2+. Fit is a
4-parameter sigmoidal fit with variables: a= 9.7226, b= 0.3574, x0= 3.2997, and yo= 14.5561.

68

1.0

0.8

fu

0.6

0.4

0.2

0.0
0

2

4

6

Urea [M]
Figure 3.15: Normalized fit according to a 4-parameter fit of chemical denature of YbiV
ΔMg2+ using circular Dichroism at 222 nm.
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Figure 3.16: Chemical denature plot (CD- 222nm) of YbiV +/ ΔMg2+ (BLACK, RED
respectively). Chemical denature clearly displays a destabilization in the absence Mg2+.
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Figure 3.17: Fit line with thermal denature data of YbiV. Fit is a 4-parameter sigmoidal fit
with variables: a= 18.0148, b= 2.0370, x0= 55.4105, and yo=- 20.07231.
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Figure 3.18: Normalized fit according to a 4-parameter fit of thermal denature of YbiV using
circular Dichroism at 222 nm.
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Figure 3.19: Fit line with thermal denature data of YbiV ΔMg2+. Fit is a 4-parameter
sigmoidal fit with variables: a= 14.4131, b= 1.5176, x0= 50.1690, and yo= -16.5185.

1.0

0.8

fu

0.6

0.4

0.2

0.0
30

40

50

60

70

80

90

o

Temperature ( C)
Figure 3.20: Normalized fit according to a 4-parameter fit of thermal denature of YbiV
ΔMg2+ using circular Dichroism at 222 nm.
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Figure 3.21: Thermal denature plot (CD- 222nm) of YbiV +/ ΔMg2+ (BLACK, RED
respectively). Thermal denature clearly displays a destabilization in the absence Mg2+.

3.3.3 Motif I Point Mutations Show Distinct Changes in Structural Stability
M. loti GmhB results on point mutations of motif I conserved residues, DxD
squiggle, displayed unique changes in stability. Asp36 when mutated to alanine exhibited
no change in stability whereas Asp 38 revealed a dramatic decrease in stability. These
changes were displayed in the GmhB protein. Can these changes be extended to other
HADs or are they specific to M. loti GmhB? To probe the generality of changes in
stability of DxD point mutants; the Asp 9 and Asp 11 to alanine mutants were created.
Point mutants were tested similar other HADs tested.
Similarly to M. loti GmhB the point mutations of YbiV's active site DxD motif
stability trends changed due to each Asp. Data presented in Table 3.3 display values that
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correlate to previous experiment D9A is as stable or more and D11A shows a
destabilization in the fold of YbiV. As seen previously, the values are consistent, Asp 2
(second Asp in DxD motif) is decreased while Asp1 tends to stabilize YbiV and play little
role in M. loti GmhB stability.
Native YbiV as well as M. loti GmhB unfold according to a 3-state model, but in
each case the elucidation of 3-state unfolding is greatly decreased when DxD mutants are
created. YbiV chemical denatures have a distinct intermediate structure seen in all three
detection techniques whereas in chemical denature of D9A and D11A, Figures 3.22-3.27,
D11A losses transition and D9A retains 3-state transition. The D9A mutant from
chemical and thermal denature proves to be a modestly more stable than the native YbiV
protein and displays a slightly longer intermediate lifespan (based in chemical denature
plots). On the other end of the spectra the D11A mutation decreased the stability of the
protein as seen in both denature techniques. From the chemical denature using
fluorescence as a detection technique the protein did not unfold according to a 3-state
model (native and D9A had distinct intermediates), to verify this loss of structure the CD
denature was obtained and showed similar but not overlaying spectra. The addition of the
two spectra also suggests a 3-state model, but the longevity of the intermediate is far less
than the native and D9A counterparts.
In M. loti. GmhB the double DxD mutant was created to test the dual-effect on
the protein stability as well as probe the possible canceling/amplifying effects when
compared to the single point mutations. Because YbiV has the included cap domain when
compared to GmhB; the double mutant D9A/D11A was created to investigate
modification to a sub-class II HAD protein.
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The double mutant was cloned and express in high yields, but when purified the
protein was unstable in native purification conditions. Protein began precipitating after
elution from Ni-NTA 6xHIS column fractions were centrifuged and transferred for
dialysis although continuation of precipitation occurred. Because stability is the target of
our experiments, the ability to stabilize the protein through additive would jeopardize our
results. From observations of purification we can assume the protein was destabilized by
the double mutation. When interpreted with point mutation data we can conclude that the
double mutation has a negative effect on the structure and stability of the protein and the
mutations create an additive effect of the destabilizing effects of the D11A point
mutation.
Tm (ºC)

Gibbs Free Energy (cal mol-1)

M (cal mol-1 M-1)

Deq (M)

WT

55.41 ± 0.10

-5685.4

-1327.8

4.28

D9A

58.65 ± 0.09

-7265.1

-1502.4

4.84

D11A

48.64 ± 0.11

-4029.3*,

-1340.5*,

3.01*

-5693.7

-1766.8

3.22

NA

NA

NA

Protein

D9A/D11A

NA

Table 3.3: Comparison of stability variables of native E. coli ybiV and DXD squiggle sitedirected mutations. Protein buffer in all experiments was 10 mM HEPES, 2.5 mM MgCl 2+ pH
7.20 with increasing urea concentration. protein concentration was ~10 µM in all
experiments. * denotes chemical denature detected by fluorescence, whereas all other
chemical denature variable are detected using CD.
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Figure 3.22: Four chemical denature sets were collected for D9A YbiV using CD. Standard
deviation from average is shown for CD detection at 222 nm. Buffer: 20 mM HEPES, 2.5
mM MgCl2+ pH 7.20 with increasing urea concentration. Protein concentration was 0.1
mg/mL.
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Figure 3.23: Fit line with averaged CD data for chemical denature of D9A YbiV. Fit is a 4parameter sigmoidal fit with variables: a= 10.4623, b= 0.3073, x0= 4.9981, and yo= -14.8837.
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Figure 3.24: Normalized fit of chemical denature data using CD for D9A YbiV.
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Figure 3.25: Four chemical denature sets were collected for D11A YbiV using CD. Standard
deviation from average is shown for CD detection at 222 nm. Buffer: 20 mM HEPES, 2.5
mM MgCl2+ pH 7.20 with increasing urea concentration. Protein concentration was 0.1
mg/mL.
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Figure 3.26: Fit line with averaged CD data for chemical denature of D11A YbiV. Fit is a 4parameter sigmoidal fit with variables: a= 10.3538, b= 0.2482, x0= 3.0045, and yo= -17.0919.
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Figure 3.27: Normalized fit of chemical denature data using CD for D11A YbiV.
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Figure 3.28: Four chemical denature sets were collected for D11A YbiV using

fluorescence. Standard deviation from average is shown for tryptophan florescence
detection at excitation: 280 and 285nm, and emission: 340 and 352 nm. Buffer: 20
mM HEPES, 2.5 mM MgCl2+ pH 7.20 with increasing urea concentration. protein
concentration was 0.1 mg/mL.
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Figure 3.28: Fit line with averaged tryptophan fluorescence data of D11A YbiV. Fit is a 4parameter sigmoidal fit with variables: a= 6632028, b= -0.3071, x0= 3.2227, and yo=
6125087
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Figure 3.29: Normalized fit of chemical denature data using tryptophan fluorescence of
D11A YbiV
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Figure 3.30: Graph includes chemical denature of native YbiV and DxD point mutations:
D9A and D11A. GREEN: D11A (CD), MAGENTA: D11A (fluorescence), RED: YbiV
(fluorescence), BLACK: YbiV (CD), and BLUE: D9A (CD). From the graph we can see
clearly that D11A is less stable and D9A is more stable than native YbiV.
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3.3.4 Asp11 Interacting Pin Residues: Role Played In Protein Structure Stability
Previous experiments on Asp11 show a destabilization in structure stability when
mutated to alanine. Does the decrease in stability result from the loss of residue when
mutated or does bonding networks play a role in destabilization? To test the underlying
reason for decreases the interacting pin residues were tested for stability when mutated to
alanine. The two residues interacting with Asp11 are Asn46 and Lys19, Figure 3.6. From
the published YbiV crystal structure (PDB: 1RLM) we see interaction between Asp11Asn46 and Asp11-Lys19, more specifically interaction between carboxylic functional
group of Asp11 and the amide of Asn46, and Asp11 carboxylic and Lys19 amine group.
Asparagine 46 was mutated to alanine to investigate effects of protein behavior.
The N46A mutant decreased activity, but did not affect structure stability. From thermal
and chemical denature changes in biophysical variables were not affected (same Tm and
+0.9 kcal*mol-1 ΔG).
Lysine 19 point mutation was attempted and successfully cloned although the
protein was ultimately found in the pellet after lyses using French press technique.
Because the K19A protein was tested due to stability issues; the double mutation
K19A/N46A protein was attempted. Similarly to the point mutation K19A the double
mutant was unstable. The protein purified using native Ni-NTA procedures, but once
eluted protein quickly precipitated in collection tube.
Interaction between Asp11 and pin residues Asn46 and Lys19 propose the idea
that without the intramolecular interactions between Asp11 and pin residue Lys19 the
protein significantly losses stability. This connection identifies key residues in HAD
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stability. To further investigate the connection between the residues, Asp11 side change
mutations were created to evaluate the specific interactions that play a key role in protein
stability.

Residue 11
Asn46

Lys19
Table 3.31: Crystal structure (PDB: 1RLM) displaying point mutations at Asp11 (ORANGE:
D11A, BLUE: Asp11, MAGENTA: D11N, and GREEN: D11E). PURPLE: pin residues
Lys189 and Asn46.

3.3.5 Side Chain Mutations of Asp11 Demonstrate Key Interactions Necessary for
Stability
As seen previously core stability is stringently connected to Asp11 and its
environment. To pin down specific interactions created by Asp11, point mutations were
created to monitor changes in protein stability. Among the discovery of stability factors
the point mutation created give an insight into possible effects created by creating nonactive proteins for ligand binding in X ray crystallography. It is a common practice in X
ray crystallography to elucidate ligand interaction in proteins to do that the ligand must
bind in native-like fashion either by substrate analogs or deactivation of protein. It is
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common in HAD proteins to deactivate the protein by mutating Asp11 to non-functional
side chains such as alanine, asparagine, and some cases glutamic acid.
A set of Asp11 point mutations were created to evaluate the change in stability
based on side chain interactions, the mutations included D11A, D11E, and D11N. To
evaluate the effect of side chain interactions thermal denature was executed and changes
in Tm observed, Table 3.5
Protein

Tm (ºC)

Native

55.41 ± 0.10

Alanine

48.64 ± 0.11

Glutamic Acid

55.77 ± 0.16

Asparagine

48.35 ± 0.12

Table 3.4: Thermal Tm values for native YbiV and Asp11 point mutants. Experiments were
carried out in 10 mM HEPES, 2.5 mM MgCl2+ pH 7.2.

Interestingly, the changes in stability as observed by Tm proposed similar results
as the pin mutation experiments. From Table 3.5 and Figure 3.7 we can see that the
carboxylic functional group is absolutely necessary for stability of the protein. In both
cases where the carboxylic acid functional group is replaced the stability is decrease (~ 7
ºC) in a similar manner compared to native Tm. The third point mutation, D11E, was
observed to be as stable as the native protein and is the only one of the point mutations
that retains the carboxylic acid side chains although it is one carbon length longer than
Asp.
From variation in side chain, it is apparent the interaction of the carboxylic acid
side chain of aspartate and glutamate are required regardless of carbon length. Although
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most interesting is the effect asparagine has on the stability of the protein. Asparagine is
the same length as aspartate but includes a amide functional group. From previous results
we have seen the interaction between Asn46 and Asp11 does not affect stability whereas
Lys19-Asp11 does, so why does the D11N affect stability? An explanation for this
distinguishment could be accredited to distinct interactions between residues. The Asp11
could be locked into a single rotomer which creates distinguishment between the two
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Table 3.31: Fit line with thermal denature data of D11A YbiV. Fit is a 4-parameter sigmoidal
fit with variables: a= 13.5179, b= 1.4598, x0= 48.6474, and yo= -16.5922.
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Table 3.31: Normalized fit for thermal denature of D11A YbiV.
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Table 3.31: Standard deviation from average is shown for thermal denature of D11E YbiV.
Buffer: 20 mM HEPES, 2.5 mM MgCl2+ pH 7.20. Protein concentration was ~.01mg/mL.
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Table 3.31: Fit line with thermal denature data of D11E YbiV. Fit is a 4-parameter sigmoidal
fit with variables: a= 8.3524, b= 1.7955, x0= 55.7723, and yo= -10.5674.
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Table 3.31: Normalized fit for thermal denature of D11E YbiV.
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Table 3.31: Fit line with thermal denature data of D11N YbiV. Fit is a 4-parameter sigmoidal
fit with variables: a= 7.4732, b= 1.1727, x0= 48.3544, and yo= -9.8842.
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Table 3.31: Normalized fit for thermal denature of D11N YbiV.
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Table 3.31: Thermal overlay of native, D11A, D11E, and D11N YbiV (BLACK, RED,
GREEN, and BLUE respectively). Data clearly shows destabilization of D11A and D11N
whereas D11E is as stable as native YbiV.

3.4 Conclusions
E. coli YbiV is a sub-type II HAD protein. It is identified by a large cap insert between
motif II and III. This elaborate cap domain has been associated with expanded substrate
binding in HAD protein. In comparison M. loti GmhB the protein is overall more stable.
This can be observed by both chemical and thermal stability values.
Albeit E. coli YbiV is more stable than its "capless" counterpart stability trends
including changes in the active site are still present. Similar to GmhB, YbiV shows a
positive effect on stability with the Asp1 mutation and a negative effect on stability when
residues interacting with or include Asp2 mutations. Combined results of experiments on
these proteins advocate trends among HAD proteins and the intricate arrangement
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between structural stability, activity, and robustness of the protein superfamily. The
underlying examination of the HAD superfamily entails the reason for the prominence
and success of the fold family among organism. Because the structural stability is linked
to the activity and success of the protein through key family trends the next logical step is
to investigate the relationship between increased activity and fold.
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CHAPTER FOUR
CRITERIA FOR EVOLUTION OF A SUCCESSFUL ENZYME
SUPERFAMILY: FOLD FITNESS AND DOMAIN DYNAMICS
EXPLORED.
4.1 Introduction
Bt4131 from Bacteriodes thetaiotaomicron is a HAD protein. Although the native
physiological role of Bt4131 is not known, it has been tentatively assigned as a
phosphatase in chitin metabolism (2). Gene context of Bt4131 suggests a role in recycling
nitrogen and carbon from the cell wall polymer chitin. Neighboring enzymes consist of
Bt4132 and Bt4127 which are (chitobiase and glucosamine-6-phosphate isomerase
respectively) (1,2). Chitobiase is an enzyme that cleaves oligomers of N-acetylglucosimine (NAG) into monomers, whereas Bt4127 recycles "NH3" though conversion
of glucosamine-6-phopshate to fructose-6-phosphate. The gene context and broad-range
sugar phosphatase activity suggests Bt4131 might function as a fructose-6-phosphate
phosphatase in chitin catabolism (1).
Bt4131 is a HAD subfamily II class B protein. The subfamily II class B is
designated by the topology of the cap insert. The cap domain is a slightly smaller /
domain; more specifically () type, Figure 4.1. The cap domain in HAD
proteins acts to interact with alcohol group of substrate for tighter binding during
catalysis. This can be observed due to accumulation of hydrophobic residues on the cap
interacting with the sugar ring of the substrate(s) (1). The many interactions between
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substrate and protein are created with binding of the phosphate group to the core domain
and hydrophobic interactions between the cap domain and metabolite, but binding is not
enough for catalysis; the protein undergoes a conformation change, wherein the active
site is sequestered from bulk solvent. Closure of the cap domain to desolvate the active
site is a major barrier in the Bt4131 reaction, Figure 4.2. Previous studies suggest an
induced fit mechanism for catalysis; this suggests that the protein must undergo a
conformation change to progress through mechanism (4). In our cases we will look at the
conformation changes due to binding ligands as well as the affect domain interacting
residues have on transitions between open and closed conformation.
For completeness Bt4131 was tested for stability similar to other HAD proteins
mentioned previously. In this chapter we look into the possible compromise between
activity and stability through investigation into point mutations in the active site and
throughout the domain - domain interface. Point mutations were created in the active site
to evaluate stability trends seen in previous proteins. Domain - domain interacting point
mutations were created to analyze effect on activity through modification of
conformation changes observed with small angle X ray scattering (SAXS). Small angle
X-ray scattering is a technique that employs high energy X ray energy to evaluate
solution conformations of proteins. As previously mentioned the subfamily II class B
HAD proteins include a cap domain that closes onto the active site initiate catalysis,
therefore we used SAXS to investigate the change in conformation due to modification of
protein or binding of substrate analogs.

91

Figure 4.1: X ray crystal structure representing Bt4131 (PDB: 2RAR). Structure represents
the subfamily II class B HAD protein: ORANGE: represents cap domain in Bt4131, BLUE:
represents the core domain, and MAGENTA: represents linkers between the two domains.

Figure 4.2: Cartoon graphic describes the process of closing the active site for catalysis.
BLUE represents open structure and RED suggests closed structure.

4.2 Material and Methods
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4.2.1 Materials
Restriction enzymes and T4 ligase were purchased from Invitrogen. Pfu Turbo
polymerase was purchased from Stratagene. Oligonucleotides were custom synthesized
by Invitrogen. Components and buffer additives were purchased from Sigma Aldrich if
not otherwise specified. DNA sequencing was performed at MC labs and by using MW
mass spectrometric determinations carried out by UNM Mass Spec Facilities.
4.2.2 Cloning and Purification of Bt4131
Wild-type Bt4131 was cloned previously (1). Cell stock containing the Bt4131
plasmid in pLyseS competent cells was used for purification. Bt4131/pET3A/pLysesS
cells were grown aerobically at 37 ºC in TB broth containing 50 µg/mL ampicillin, and 4
mL glycerol to an O.D600 0.7 - 0.9 and induced for production of protein by addition of
0.1 mM isopropyl--D-galactopyranoside (IPTG). Following a 12 h induction period at
18 ºC, cells were harvested by centrifugation at 6,500 rpm for 10 min, resuspended in 10x
weight Buffer A (50 mM HEPES pH 7.5), and lysed using French press at 1,200 psi.
Lysate was centrifuged at 20,000 rpm and 4 ºC for 20 min., giving a supernatant that was
fractioned using ammonium sulfate induced precipitation. The 50-80% (w/v) ammonium
sulfate fraction was collected by using centrifugation at 20,000 rpm, 4 ºC for 20 min. The
collected pellet was resuspended in 30 mL Buffer B (50 mM HEPES, 12% (NH4)2SO4
pH 7.5, and loaded onto a 10 x 30 mm (HR10 column) BS Sepharose column, pre
equilibrated with Buffer B at 4 ºC. The column was washed with 5 CV Buffer B and
eluted with a linear gradient (10 CV) 100 - 0% Buffer B (12% -0% (NH4)2SO4). Fractions
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were analyzed by using SDS-PAGE, and those containing the desired protein were
combined and concentrated using 10K Amicon Ultra Centrifugal filter.

4.2.3 Site-Directed Mutagenesis
Site-directed mutagenesis (SDM) was carried out using the Quick Change PCR
Strategy (Stratagene). Plasmid was used as template with custom oligionucleotides
expressing mutated condon (s). Pfu Turbo polymerase was used to copy mutated PCR
product. Recombinant mutants plasmids were transformed into pLyseS competent cells
and used in 10 mL scale cultures for expression. Cultures showing expression of protein
were subjected to either gene sequencing or mass spectrometric analysis. All mutants
were cultured and purified using the procedure employed for the wild-type (WT) protein.

4.2.4 Determination of SteadyState Kinetic Constants
The kcat and Km values for native and mutant Bt4131 against glucose-6-phosphate
were determined using the method described in Chapter 2.

4.2.5 Thermal Denature Monitored by Using Circular Dichroism
Circular dichroism was used to observe changes in the secondary structure of
Bt4131 as a function of temperature. Procedures and fitting models used to analyze the
data are described in Chapter 2.
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4.2.6 Chemical Denature Monitored by Using Circular Dichroism, Fluorescence and
SAXS
Three techniques were used to probe changes in the structure of Bt4131 promoted
by addition of urea. Tryptophan fluorescence was used to monitor changes in the
surroundings and local polarity of aromatic (mainly tryptophan) residues. To observe
changes in the secondary structure of the protein, circular dichroism was used at
wavelengths 222 and 217 nm. Finally, to monitor changes in the tertiary structure, small
angle scattering was employed. SAXS data were used to generate a calculated solution
volume, which is used to determine the general shape of the solution conformation of the
protein. Procedures and fitting models for handling the chemical denaturation data are
discussed in Chapter 2.

4.2.7 Preparation of SAXS Samples
Recombinant Bt4131 in stock solution was concentrated to 30 mg/mL. Individual
stock solutions (200 mM) of sodium metavanadate (VO3), 2-deoxy-d-glucose, and dribose were prepared in 0.22 µM filtered 18MΩ deionized water (typically stock ligands
would be in dialysis buffer, but multiple samples were tested using stock solutions).
Metavanadate (VO3) was used to mimic phosphate mimic and both d-ribose and 2-deoxyd-glucose were used to mimic substrate. Prior to sample collection, the solution
containing the protein was centrifuged at 14,000 rpm 4ºC for fifteen min to ensure
possible aggregates are pelleted. Protein and substrate solutions were diluted with dialysis
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buffer to proper concentrations (protein range 0.5-30 mg/mL, substrate analogs 10x KI)
and placed in PCR strips for SAXS analysis.

4.2.8 Collection of SAXS Data
SAXS data were collected at beamline 4-2 at the Stanford Synchrotron Radiation
Lightsource (SSRL). Samples subjected to this technique were prepared by mixing
protein and matched buffer each ligand concentration. During collection, samples were
held at 10 ºC using an aluminum block. Then, 30µL of a sample, drawn into a capillary
using an automated fluid handling system, was subjected to ten-seventeen 1 s exposures
giving data that were collected using a Pilatus 300K photon detector at a distance of 0.
5m covering a range of 0.013 < q5 < 1.23. Scattering profiles were processed using the
BL4-2 SasTool utility program (5).

4.2.9 Theoretical Interpretation of Protein Conformation
To interpret data arising from SAXS experiments, the absolute scattering profiles
of open and closed conformations of HAD proteins, with previously determined X ray
crystal structures, were used in the to create theoretical scattering profiles Table: 4.1.
Because the open conformation Bt4131 does not crystallize, Phyre2 was used to thread
the Bt4131 amino acid sequence through a known open conformation HAD protein
,TM0651, from Thermotoga martima (9). To create scattering profiles FoXS (7,8) and
CRYSOL (6) were used
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PDB ID

Ligand

Resolution (Å)

Conf. State

1YMQ

Mg, SO4

1.90

D10A closed

2RBK

Mg, VO3

1.00

Closed

1YMQ*

Mg, SO4

1.90

Open

Table 4.1: Crystal structures used to investigate different conformations of Bt4131. 1YMQ*
signifies open conformation of 1YMQ determined using Phyre2 modeling of Bt4131 sequence
with PDB: 1RLO.

4.3 Results and Discussion
4.3.1 Stability of Bt4131 and Effects of Active Site Mutation
Recombinant Bt4131 is a sub-type II HAD protein similar to E. coli YbiV. We
have observed trends that follow through both capped CII and capless C0 HAD proteins.
In this chapter we want to investigate the affect and mutation on catalysis observed
through changes in solution conformation. To inspect the generality of stability trends
amongst HAD proteins stability experiments were tested on Bt4131 Table 4.2 and
Figures 4.3-4.9.
Akin to the previous two proteins tested, Bt4131 showed to unfold according to a
3-state model Figure 4.8. Although the transitions do not include a notable intermediate
we can infer the extra state due to the separate transitions among different detection
limits.
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Technique

ΔG (cal*mol-1)

m (cal*mol-1*M-1)

Fluorescence

-

-

Circular Dichroism (CD)

-3646.7

-1466.4

2.49

Small angle X ray scattering -4606.6

-2590.0

1.78

deq (M)

(SAXS)

-1

-10

Molar Elipticity [deg cm dmol

-5

2

Table 4.2: Bt4131 chemical denature using urea with different observation techniques. All
reactions were carried out in 20 mM HEPES, 2.5 MgCl2. pH 7.2 with increasing urea
concentration. Protein concentration was ~ 10 µM.
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Figure 4.3: Raw chemical data from chemical denature of Bt4131 using CD. Error bars are
standard deviation from average of 4 data sets. To ensure protein unfolds equally both 217 and
222 nm wavelength was collected and verified to overlay each other.
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Figure 4.4: Fit line with averaged CD data for chemical denature of Bt4131. Fit is a 4parameter sigmoidal fit with variables: a= 22.9957, b= .3773, x0= 2.5088 and yo= -32.2096

1.0

0.8

fu

0.6

0.4

0.2

0.0
0

2

4

6

Urea [M]
Figure 4.5: Normalized fit of chemical denature data using CD for Bt4131.
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Figure 4.6: Fit line with small angle X ray scattering data for chemical denature of
Bt4131. Fit is a 4-parameter sigmoidal fit with variables: a= 36.6441, b= 0.2265, x0=
1.7909, and yo= 21.5256. Rg was calculated for each [urea] using PRIMUS.
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Figure 4.7: Normalized fit according to a 4-parameter fit of chemical denature of Bt4131
using SAXS.
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Figure 4.8: Overlay of chemical denature of Bt4131 with different observational techniques.
Because denature plots do not overlay suggests the protein unfolds through a 3-state model.
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Figure 4.9: Calculation of combined theoretical 3-state denature curves at different
molar ratio of intermediate conformation. From left to right, individual colors
represent different molar fraction of intermediate from 0.0 to 1.0 by increments of 0.1.
Solid DARK PURPLE: chemical denature using SAXS, GREEN SHORT DASH:
chemical denature using CD.
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4.3.2 Effect of Mg2+ Cofactor on Structural Stability
We have already recognized the importance of binding the Mg2+ cofactor in HAD
proteins; results from E. coli YbiV display a decrease in stability and loss of activity
when cofactor was not present. Bt4131 displays similar trend to YbiV. This decrease in
stability can be attributed to changes in charge of the active site, i.e. a decrease in lysine
in active and increase in aspartate.
Thermal denature of Bt4131 with and without cofactor resulted in a loss of
stability when Mg2+ was not present 53.84 ± 0.09 and 50.05 ± 0.05 respectively, Figures
4.13-4.18. Common amongst all thermal denature experiments is the loss of 3-state
unfolding and in this case we see no intermediate which suggests a 2-state unfolding
model. Unlike the GmhB the loss of cofactor destabilized both capped C2 HAD proteins.
The similarity between C2 proteins and difference from GmhB suggests a key role albeit
small in stability of specific protein.
Previous explanation for the intermediate structure suggests a loss of
intramolecular interactions between two possible sub-units of the core domain. The
deficient Mg2+ experiments support this theory that the accumulation of the cap domain
in the C2 proteins create a greater strain on the interaction between sub-units. Interactions
between Mg2+ and Asp residues reside on the interacting surfaces of the two sub-units
suggesting a role in increased affinity between sub-domains. A second theory could be
attributed to the changes in charge of the active site Figure 4.10-4.12. In GmhB there are
2 lysines and 3 aspartates interacting near Mg2+ whereas in the capped C2 proteins an
additional Asp is present and loss of Lys.
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Figure 4.10: Displays the active site of M. loti GmhB. From the figure you can see
three aspartates and 2 lysines near active site which suggest a neutralization of charge
in the absence of Mg2+.

Figure 4.11: Displays the active site of E. coli YbiV. From the figure we can see that
the loss of lysine and addition of aspartate could destabilize the charge equilibrium
when Mg2+ is not present.
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Molar Elipticity [deg cm2dmol-1

Figure 4.12: Displays the active site of Bt4131. From the figure we can see that the
loss of lysine and addition of aspartate could destabilize the charge equilibrium when
Mg2+ is not present.
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Figure 4.13: Fit line with CD data for thermal denature of Bt4131 +Mg2+. Fit is a 4parameter sigmoidal fit with variables: a= 30.2542, b= 1.4810, x0= 53.8440, and yo=
-39.7638.
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Figure 4.14: Normalized fit according to a 4-parameter fit of thermal denature of
Bt4131 +Mg2+ using CD
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Figure 4.15: Three thermal denature sets were collected for Bt4131 ΔMg2+ using CD.
Standard deviation from average is shown for 222 nm detection. Buffer: 20 mM HEPES, 5.0
mM NaCl pH 7.20. Protein concentration was 0.1 mg/mL
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Figure 4.16: Fit line with averaged thermal CD data for Bt4131 ΔMg2+. Fit is a 4-parameter
sigmoidal fit with variables: a= 29.6701, b= 1.5126, x0= 50.0505, and yo= -31.9956.
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Figure 4.17: Normalized thermal denature fit line for Bt4131 ΔMg2+.
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Figure 4.18: Overlay of thermal denature of Bt4131 with/without Mg2+ (BLACK, RED
respectively). Plot clearly shows a destabilization when cofactor is absent.

4.3.3 Active site residues and the effects on stability when mutated
In previous chapters we have looked into the stability of the protein with active
site mutations and the two that make the most impact are the two aspartates involved in
the dephosphorylation of the substrate. In Bt4131 the two residues are D8 and D10.
From the thermal denature we can see similar trends in the two mutations D8A and D10A
with Tm of 52.17 ± 0.008 and 43.6 ± 0.5 respectively. Again we see the same trend of the
first aspartate in the DXD motif is either stabilizing or have essentially no effect on the
stability of the protein; whereas the D10A mutation decreases the stability of the protein
Table 4.3.
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Protein

Tm (ºC)

WT

53.8 ± 0.1

D8A

52.2 ± 0.1

D10A

43.6 ± 0.5

Table 4.3: Comparison of stability variables of native Bt4131 and DXD squiggle site-directed
mutation. Protein buffer in all experiments was 20 mM HEPES, 2.5 mM MgCl2+ pH 7.20.
Chemical denature done with increasing urea concentration. protein concentration was ~10
µM in all experiments.

4.3.4 Activity and Stability of Domain Interfacing Point Mutations
To explore ligand induced conformation changes in Bt4131 both activity and
stability of each point mutation was obtained Table 4.4. From Tm comparisons between
domain-domain interacting point mutations we can see they play little to no part in
structure stability with all mutations (except D10A) varying by ± 1.8 ºC from native
Bt4131 Tm. Drastic variation in activity base on domain interfacing point mutation
suggest connection between activity and interactions between cap and core.

108

Protein

Tm (ºC)

kcat

km

WT

53.84 ± 0.09

3.6 ± 0.2

11 ± 2

D8A

52.17 ± 0.08

---

D10A

43.6 ± 0.5

R45A

53.96 ± 0.09

R45K

53.92 ± 0.06

K47A

55.77 ± 0.09

---

N51A

54.74 ± 0.11

---

1

2 x 10-4
1

1

1

1

ND

5 x 10-3

1

kcat /km

14

ND

5 x 10-3

Table 4.4: Includes the changes in stability and activity when compared to native Bt4131.
All thermal denatures were carried out in same buffer, 20 mM HEPES, 2.5 mM MgCl 2 and
pH 7.2. Activity was tested using Enzchek assay. 1corresponds to published kinetic values for
specific mutations.

4.3.3

Crystal

Structure

Generated

Scattering

Profiles

Display

Distinct

Conformations
Scattering profiles display very distinct conformations depending on apo or
liganded, Figure 4.19. From the CRYSOL generated scattering profiles, Figure 4.20, we
can see that SAXS can distinguish conformational difference between the open and
closed structures. Although SAXS cannot distinguish small changes; the techniques
allows us to investigate near native solution conditions and how the protein reacts and
shifts especially during the progression of reaction. From the theoretical scattering plots
generated by CRYSOL we can look distinct modifications in low and mid q-range
intensity.
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Figure 4.19: Overlay of Bt4131, PDB: 2RBK and Phyre generated structure of
Bt4131. ORANGE displays the close conformation of Bt4131 whereas BLUE
displays the generated open conformation of Bt4131.
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Figure 4.20: Theoretical scattering profiles for Bt4131 in open and closed
conformation (RED, BLACK respectively). Profiles were generated from PDB
structures (1YMQ* and 1YMQ) using CRYSOL.
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4.3.5 Ligand Binding Induces Conformation Changes in Bt4131
Recombinant Bt4131 samples were exposed in the absence and presence of
substrate analogs. Substrate analogs were used to bind similar to substrate without
reacting; ligands were tested with protein at varying concentration (0-50 mM). Ligands
included sodium metavanadate (VO3), d-ribose and 2-dexoy-d-glucose Table 4.5.
From collected SAXS we can see distinct changes in conformation Figures 4.214.23 whereas predominant changes in structure were observed in samples that contained
VO3. Sodium metavanadate acts as a phosphate analog, which suggests binding of the
phosphate group to active site of the core domain initiates a conformation change
although changes in conformation due to sugar moiety binding was not near as extreme
some samples induced a change in structure. Combination of both VO3 and sugar moiety
induced change similar to conformation change with VO3 independently.
Scattering data support an induced-fit mechanism of catalysis. For catalysis to
occur a conformational change must occur to sequester bound substrate and active site
from bulk solvent. Results suggest binding of substrate analogs initiates catalysis with
binding of VO3 inducing the largest change followed by VO3 with d-ribose. Observed
results show minimal change when binding sugar moiety but in the presence of vanadate
change is substantially increased. Changes made by bound VO3 were not seen in any
other samples which could be accredited to the increased volume in the active when
bound with VO3 and sugar moiety. Off all the sugar moieties bound 2-doexy-d-glucose
was the only ligand than induced a change in conformation, which is interesting because
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2-deoxy-d-glucose is the suggested native substrate. This result may suggest a evolved
interaction between native sugar moiety and cap domain which allows initiation of
catalysis. From a collective view of substrate analog binding experiments we can
conclude that Bt4131 progresses through an induced-fit mechanism tailored to activation
through binding phosphate group and native substrate analog.

Substrate Present

Guinier Rg

P (r) distribution Rg

dmax

Empty

19.55

19.39

68.43

2-deoxy-d-glucose

19.26

19.03

63.09

d-riboose

19.18

19.26

67.14

l-arabinose

20.59

20.73

72.09

Pyridoxal

20.56

20.78

72.02

VO3

18.79

18.62

57.31

2-deoxy-d-glucose + VO3

18.88

18.73

63.24

d-riboose + VO3

18.75

18.70

58.60

l-arabinose + VO3

20.49

20.16

71.70

Pyridoxal + VO3

20.18

20.43

70.61

Table 4.5: shows the calculated SAXS variable Rg (from Guinier and P(r) Distribution) as
well as the dmax (calculated from P(r) Distribution). All experiments were runs at multiple
concentrations with ligand in excess in 50 mM HEPES, 5mM MgCl2, 75 mM NaCl, and 1
mM DTT, pH 7.0
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Figure 4.21: Kratky plot of Bt4131 w/wo substrate analogs. 6 experimental plots are
represented although 2 distinct shapes are seen. Cool colors teal, green, blue) represent
Bt4131 (empty, d-ribose, or 2-deoxy-d-glucose).Warms colors (red, orange, and pink)
represent Bt4131+ VO3 ± (d-ribose, or 2-deoxy-d-glucose). B and C are magnifications of key
regions in scattering plots.
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Figure 4.22: Kratky plot of Bt4131 w/wo substrate analogs. 5 experimental plots are
represented although 2 distinct shapes are seen. Cool colors (black, green, blue) represent
Bt4131 (empty, l-arabinose, or pyridoxal).Warms colors (red and pink) represent Bt4131+
VO3 + (l-arabinose, or pyridoxal).

vanadate.
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Figure 4.23: magnified Kratky plot (Figure 4.19) of Bt4131 w/wo substrate analogs. 5
experimental plots are represented although 2 distinct shapes are seen. Cool colors (black,
green, blue) represent Bt4131 (empty, l-arabinose, or pyridoxal).Warms colors (red and pink)
represent Bt4131+ VO3 + (l-arabinose, or pyridoxal).

RED: l-arabinose + vanadate.
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4.3.6 Domain-Domain interacting mutations and Solution Conformational changes
induced.
After identifying the ligand responsible for induced closure of Bt4131, the next
step is to identify key residues responsible for stabilization of a cap-closed conformation;
most notable are domain-domain interacting residues. The table below lists the mutations
tested and the values obtained Table 4.6. As we can see the mutations have a variety of
effects on the empty solution conformations Figure 4.24. This set of results without
substrate analogs identifies that the changes in these residues indeed effects the
conformation and thus our activity, the table below Table 4.6 displays the effects on Rg
and dmax when protein is with/without substrate analogs 2-deoxy-d-glucose and vanadate
(the substrate used to investigate closure of cap were determine based on changes
observed in the native protein). From previously proposed theories on induced
conformational changes in proteins is necessary for catalysis (Johnson) we can see factors
into activity in this C2 HAD protein through cap closure induced by phosphate binding.
In a specific case, R45A, had no activity and from our scattering experiments we can see
that there is no changes in conformation when binding vanadate in combination with
sugar metabolites (substrate analogs) Figure 4.25. This case helps demonstrate the
necessity of cap movement in activity. Other mutants that do not move are R45K, and
D8A.
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Figure 4.24: Kratky plot of SDMs of Bt4131 (Apo). From graph we can see that the proteins
occupy many equilibrium conformations without ligand binding.
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Figure 4.23: Scattering profile of R45A with and without substrate. As you can see the
protein does not undergo any conformation change due to ligand binding (2-deoxy-d-glucose
and VO3).
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Bt4131

13R
g

24R
g

13R
g

24R
g

1d

WT

19.529 ± 0.315

19.087 ± 0.400

19.33

18.82

68.35

64.85

D8A

19.132 ± 0.353

17.036 ± 0.930

19.43

19.21

62.66

55.80

D10A

19.304 ± 0.558

18.449 ± 0.159

19.30

18.44

58.88

54.89

F16A

27.323 ± 1.247

28.789 ± 2.778

25.79

25.73

87.43

87.81

R45A

19.346 ± 0.178

19.330 ± 0.093

19.26

19.29

60.46

58.96

R45K

20.019 ± 1.043

19.339 ± 1.281

20.12

19.69

70.07

67.69

K47A

18.723 ± 0.200

17.798 ± 0.221

18.87

18.33

57.11

54.28

N51A

19.809 ± 0.197

NA

19.80

NA

67.84

NA

E77A

19.162 ± 0.257

17.727 ± 0.368

19.51

18.69

61.32

57.74

max

2d

max

Table 4.6: Table includes Rg and dmax values for SD point mutation with and without substrate
(vanadate and 2-deoxy-d-glucose). 1 represents protein without ligands, 2 denoted protein with
ligands.

4.4 Conclusion
Once again we have seen similar stability effects due to changes in active site
residues. Similar to other proteins examined, Bt4131 shows no change in stability due to
D8 mutation, but a decrease in stability due to D10 mutation. We have seen the same
trends through many different proteins, but do the changes correspond to a change in
structure?
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Small angle X ray scattering was used to investigate how the mutations effect the
solution conformations and if so how does it affect activity. The DXD mutants showed
similar structures and scattering values; the major difference between them and native
protein was the difference between open and closed conformations.
As we have seen the stability of Bt4131 is similar to the other C2 HAD proteins
tested. In all tested proteins the DXD plays a large role in protein stability. The stability is
affected similar in the C2 capped proteins when Mg2+ is absent. In this chapter we used
SAXS to connect fold and activity. From collected data we see that both interaction
between residues at the interface and interaction between parts of substrate modify
conformations. Results displayed two distinct conformations with the closed structure
being stabilized with the binding of substrate analogs VO3 and VO3 + sugar moiety.
Tested domain-domain interfacing residues modified structure as well, with the most
interesting being R45A, R45K, D8A, and F16A. The Arg45 mutants and Asp8 mutants
did not induce changes in structure whereas F16A displays a completely unique structure
compared the rest. SAXS data helps establish a connection between solution structure
and activity.
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CHAPTER FIVE
PROTEIN STABILITY AS A FUNCTION OF DOMAIN

5.1 Introduction
Previous studies on multi-domain proteins suggest that the stability of the 'host
domain" (core domain) increases when a "guest domain" (cap domain) is absent (1). The
stabilities of two sub-types in the HAD superfamily have been described previously.
Proteins in each subfamily display similar stability traits associated with their active site
residues and cofactor affinities, but members of each group have the ability to
discriminate substrate binding through the presence of unique adornments such as loops
and larger cap domains. Although the core domains are similar in these subgroups, the
cap portions vary, which leads to differences in overall stabilities.
It is widely believed that the acquisition of a new activity by a protein
compromises stability (1-3). A new function of HAD members would be introduced not
only by a change in the mechanism of the catalyzed reaction but also by a change in cap
residues involved in substrate binding. In this context, we asked the following important
question. How does insertion of the cap domain affect the stability of the core domain of
a HAD member. To gain information about this issue, proteins having domains present in
two representative HADs, YbiV and Bt4131, were prepared and their stabilities were
assessed. The six protein generated by using this strategy included the separate core and
cap domains of YbiV and Bt4131 and, two chimera proteins, in which the cap domains of
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YbiV and Bt4131 are swapped (Figure 5.1). The activities and structures of these two
chimera proteins have been evaluated in a previous study (2). Stability, activity, and
structure based investigations with the six truncated proteins were carried out in order to
elucidate the complete story about why the HAD protein family is so robust and
abundant.

Figure 5.1: Cartoon representation of engineered truncations of YbiV and Bt4131. BLUE:
YbiV and ORANGE: Bt4131.
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5.2 Methods and Material

5.2.1 Synthesis of Hybrid Proteins
The constructed proteins were synthesized using Genetech Technologies. Proteins
were codon optimized and transformed in both pUC57 and pET 28a vectors.

5.2.2 Purification of Capless ybiV
The capless YbiV protein plasmid capless YbiV/pET28a was transformed into
Bl21 Iq competent cells using a given protocol. The capless YbiV/pET28a/Bl21 Iq cells
were grown aerobically at 37 ºC containing 50 µg/mL kanamycin in LB broth to an
O.D600 0.6-0.9 and induced for production of protein by adding 0.4 mM isopropyl--Dgalactopyranoside (IPTG). Following a 12 h induction period at 18 ºC , cells were
harvested by centrifugation at 6,500 rpm for 10 min at 4 ºC. Harvested cells were
resuspended in 10 x weight lysis buffer (40 mM HEPES, 200 mM NaCl, 50 mM
imidazole pH 7.5). Resuspended cells were lysed using a Amico French press at 1,200
psi, lysate was centrifuged at 20,000 rpm for 20 min 4 ºC. Supernatant from the
centrifugation was loaded onto a NTA-Ni HisTrap FF 5 mL column (GE Life Sciences).
The column was washed with lysis buffer and eluted using elution buffer (40 mM
HEPES, 200 mM NaCl, 500 mM imidazole pH 7.5). Column fractions were tested for
protein using SDS-page gel. All fractions containing pure protein samples were combined
and dialyzed at 4 ºC against 3 changes 2L/2L/4L of 50 mM HEPES, 50 mM NaCl, 5mM
MgCl2 pH 7.3. The protein yield was ca. 15 mg/g wet cells.
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5.2.3 Purification of Capless Bt4131
The Capless Bt4131 plasmid, CBt4131/pET28a, was transformed into Bl21 Iq
competent cells using a directed protocol. The CBt4131/pET28a/Bl21 Iq cells were
grown in a manner that is similar to that of the Capless YbiV with the exception of the
final dialysis, which consisted of 3 rounds at 4 ºC 2L/2L/2L of 50 mM HEPES, 50 mM
NaCl and 5 mM MgCl2 pH 6.8. The protein yield was ca. 10 mg/g wet cells.

5.2.4 Purification of Bt413-Cap
The Bt4131 Cap plasmid, Bt4131C/pET28a, was transformed into Bl21 Iq competent
cells using a directed protocol. The Bt4131C/pET28a/Bl21 Iq cells were grown in a
manner that is similar to that of the protocol described above with the exception of the
final dialysis, which consisted of 3 rounds at 4 ºC 2L/2L/2L of 50 mM HEPES, 50 mM
NaCl and 5 mM MgCl2 pH 6.8. The protein yield was ca. 12 mg/g wet cells.

5.2.5 Purification of ybiV-Cap
The YbiV Cap plasmid, YbiV-(cap)/pET28a, was transformed into Bl21 Iq competent
cells using a directed protocol. The YbiV-(cap)/pET28a/Bl21 Iq cells were grown in a
similar manner (see above) with the exception of the final dialysis; which consisted of 3
rounds at 4 ºC 2L/2L/2L of 50 mM HEPES, 50 mM NaCl and 5 mM MgCl2 pH 7.0. The
protein yield was ca. 15 mg/g wet cells.

5.2.6 Purification of Chimera ybiV(cap)/Bt4131 protein
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The chimera YbiV(cap)/Bt4131 protein plasmid ybiV-Bt4131/pET28a was
transformed into Bl21 Iq competent cells using the given protocol. The ybiVBt4131/pET28a/Bl21 Iq cells were grown in a similar manner (see above) with the
following exceptions. This protein in less stable than the previous constructs and
undergoes precipitation during elution and dialysis. When precipitation occurred, the
protein sample was centrifuged for 5 min at 6500 rpm at 4 ºC. The supernatant was
dialyzed with 3 buffer exchanges 2L/2L/2L of dialysis buffer (50 mM HEPES, 150 mM
NaCl, and 5 mM MgCl2 pH 7.0). The protein yield was ca. 10mg/g wet cells.

5.2.7 Purification of Chimera ybiV-core/Bt4131 protein
The chimera YbiV(core)/Bt4131 protein plasmid ybiV-Bt4131/pET28a was
transformed into Bl21 Iq competent cells using a given protocol. The ybiVBt4131/pET28a/Bl21 Iq cells were grown in a similar manner (see above) with the
exception of the final dialysis, which consisted of 3 rounds at 4 ºC 2L/2L/2L of 50 mM
HEPES, 50 mM NaCl and 5 mM MgCl2 pH 7.0. The protein yield was ca. 12 mg/g wet
cells.

5.2.8 Site-Directed Mutagenesis
Site directed Mutagenesis was carried out using the Quick Change PCR Strategy
(Stratagene). WT plasmids were used as templates and mutant plasmids were employed
as templates when multiple mutations are generated for PCR amplification,
oligionucleotides including mutated codon as primer and Pfu Turbo polymerase
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(Strategene). Recombinant mutant plasmids were transformed into BL21 (DE3) Iq using
small scale cultures for expression. Cultures showing expression of protein were verified
using either gene sequencing or mass spectrometric analysis All mutated proteins were
cultured and purified employing the protocol used for wild-type (WT) proteins.

5.2.9 Determination of Steady-State Kinetic Constants
Kcat and Km values were determined using Enzchek phosphate assay kit, when
applicable. This assay procedure is described in Chapter2.

5.2.10 Assessing Thermal Denaturation Using Circular Dichroism
Changes in the circular dichroism spectra as a function of temperature were used
to detect changes in the secondary structures of the proteins. The procedures and fitting
models employed for this purpose are described in Chapter 2.

5.2.11 Chemical Denaturation of Ordered Protein Structure
Three techniques were used to investigate the ordered structure of the truncated
and chimeric proteins. Tryptophan fluorescence was used to investigate changes in the
environment of aromatic amino acid residues (mainly tryptophan). To observe changes in
the secondary structure of the protein, circular dichroism measurement were made at 222
and 217 nm. In order to evaluate changes in the tertiary structure, small angle scattering
was employed. SAXS was used to generate a calculated solution volume, which was then
126

employed to identify the general shape of the protein in solution. The procedures and
fitting models utilized in the chemical denaturation experiments are described in Chapter
2.

5.3 Results and Discussion
5.3.1 Constructed Capless Proteins (Capless YbiV, Bt4131) Exhibit Stabilities that
Are Similar to Those of the Corresponding Native Proteins
To activities and stabilities of the truncated capless proteins were investigated to
assess the possible destabilizing effects of cap domain inserts. Table 5.1 displays stability
related values arising from the chemical and thermal denaturation studies. Importantly,
the data show that both capless proteins are as or more stable than the corresponding
native proteins Bt4131 and YbiV. In addition, the chemical denaturation data, and in
particular differences in changes detected by using fluorescence and CD, demonstrate
that capless YbiV unfolds by using a 3-state process. In previous studies with GmhB,
YbiV and Bt4131, we observed that the fluorescence and CD denaturation profiles are
similar and differ from those arising from SAXS measurements. Furthermore, although it
is likely that capless Bt4131 also folds through a 3-state pathway, the shortage of data
arising from a secondary observational technique prevents an unambiguous assignment of
this route.
The data arising from studies with GmhB, YbiV and Bt4131, and the two capless
proteins derived from Bt4131 and YbiV enables the reasonable conclusion that the core
Rossmann-like domain in these proteins folds through a 3-state pathway Most notable is
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the fact that capless proteins do not display a large increases in their stabilities, a result
that suggests that the stability of the core domain is not greatly affected by changes
associated with the addition of cap domains.
Protein

TM

ΔG (cal*mol-1)

m (M*cal*mol-1)

deq
(M)

Bt4131

53.84 ± 0.09

-3646.71

-1466.41

2.493

Bt4131 Capless

51.43 ± 0.15

-3757.51

-1321.01

2.843

YbiV

55.41 ± 0.10

-5685.41

-1327.81

4.283

YbiV Capless

57.00 ± 0.05

-4497.11

-1292.11

3.483

9718.82

2748.72

3.533

Table 5.1: Table shows the denature values, thermal and chemical denature, for both the WT
and Capless proteins tested.

5.3.2 Structure Determination of Capless Proteins
In a preliminary effort, crystal trays (hanging drop method) were set up to test
possible crystallization conditions for both capless Bt4131 and capless YbiV. Because the
capless proteins are comprised of cores only, the starting conditions used were those
employed for crystallization of M. loti GmhB (Structural Genomics Center). Under the
tested conditions some crystals grew (Figure 5.2-5.3). For example, capless Bt4131 grew
long thin rod-like crystals in 25% PEG 3350, 0.1 mM MES, 5mM CaCl2 pH 6.5, whereas
capless YbiV grew rectangular crystals in 0.1 M Bis-Tris, PEG 3350 20% pH 5.5, and 0.1
M MES, 5mM CaCl2, PEG 3350 25% and 0.2 M (NH4)2SO4, pH 6.5. Although the sizes
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of the crystal are too small to be useful for crystallographic studies, this effort ha created
a starting point for optimization of conditions to allow larger crystal growth.

Figure 5.2: Crystals grown for capless Bt4131. Crystal conditions: 25% PEG 3350, 0.1 mM
MES, 5mM CaCl2 pH 6.5. Crystal are the same conditions two separate wells

B

Figure 5.3: Crystals grown from capless YbiV protein. Crystal conditions A: 0.1 M Bis-Tris,
PEG 3350 20% pH 5.5, and B: and 0.1 M MES, 5mM CaCl2, PEG 3350 25% and 0.2 M
(NH4)2SO4, pH 6.5
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In order to determine if the capless proteins are folded in solution, the small angle
scattering techniques was employed. Inspection of the scattering profiles of both capless
Bt4131 and capless YbiV, displayed as Kratky plots in Figure 5.4, shows that each
protein has a defined tertiary structure.

Scattering Intensity (I*s 2)

8

6

4

2

0
0.0

0.1

0.2

0.3

0.4

q
Figure 5.4: Kratky plot of capless YbiV (BLUE) and capless Bt4131 (RED) overlaid with
scattering profile of protein without structure (BLACK).

5.3.3 Cap Proteins are stable in Absence of Core Domains
The results show that the capless HAD proteins are as stable as their native
counterparts. Our studies were next directed at determining the stabilities of the two cap
domains. In attempts to purify both proteins in large quantities, precipitation occurred
during dialysis although soluble protein was collected. Both proteins were thermally
denatures to investigate the stability. From thermal denature of the cap-only proteins we
can see that both caps are stable (Tm 48.0 ± 1.5, and 52.5 ± 0.5 for YbiV-(cap) and
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Bt4131-cap respectively). From the collected cap-protein thermal we can conclude that
the cap only proteins are as stable as the core domains separately. With a stable core and
cap domain separately we can infer stability when the two domains are together seen in
the native protein structures

5.3.4 HAD Active Site Point Mutation Trends Observed in Capless Proteins
In previous chapters, we described the effects of active site point mutations on the
stabilities of HAD proteins. Observations made show that effects of specific point
mutations display trends. Because the truncated capless YbiV and capless Bt4131
proteins have been shown to fold and are stable, active site point mutations were created
to see if the stability trends are also followed by the mutant truncated proteins. The
results of studies with these proteins show that the effects of mutations follow similar
trends in both the native and capless proteins. The D9A (capless YbiV) and D8A (capless
Bt4131) have similar stabilities to their respective native capless proteins (Table 5.2). As
predicted, the D10A and D11A mutants have substantially lower Tm values (ca. 22 ºC for
capless YbiV and precipitated capless Bt4131) corresponding to lower stabilities. Point
mutations at third aspartic acid moiety (Asp122) of capless YbiV that interacts with Mg 2+
in the native structure do not alter the stability of the protein as reflected by both the Tm
and ΔG values. One noticeable difference between the native protein and capless Bt4131
is that D8A/D10A mutation of the capless protein leads to recovered stability
corresponding to an increase in Tm. The changes in stability brought about by point
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mutations can be attributed to changes in the of interactions between the side chains of
the cap and core amino acids and switches to interactions with solvent.

Tm (°C)

ΔG (cal*mol-1)

m (M*cal*mol-1)

deq [M]

51.43 ± 0.15

-3841.6

-1366.8

2.81

D8A

59.53 ± 0.07

-4791.4

-1065.7

4.50

D10A

ND*

ND*

ND*

ND*

-4497.1

-1292.1

3.48

-4825.3

-1079.9

4.47

Protein
Capless Bt4131

D8A/D10A

Capless YbiV

49.09 ± 0.15

57.00 ± 0.05

D9A 58.44 ± 0.08
D11A

35.35 ± 0.11

D122A

61.79 ± 0.08

Table 5.2: Table shows the denature values, thermal and chemical denature, for both coreonly proteins (Capless Bt4131 and Capless YbiV) and corresponding aspartate mutants
(catalytic and cofactor binding (Mg2+) mutants.

5.3.5 Folding of the Bt4131-core/YbiV-cap protein.
The recombinant chimeric protein Bt4131-core/YbiV-cap, constructed and
purified on a large scale, was found to be instable (Table 5.3). Circular dichroism studies
showed that this protein has a preserved secondary structure at 20 ºC. Kinetic analysis
demonstrated that this chimeric protein does not catalyze hydrolysis of ribose-5phosphate, glucose-6-phosphate, or para-nitrophenyl phosphate (pNPP). Thus results
suggest that destabilization is caused by fusing the these cap and core domains but that
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this effect does not alter the ability of the protein to fold, indicating that folding of the
core domain is able to endure the destabilizing incorporation of the non-natural cap.

TM

ΔG (cal*mol-1)

m (M*cal*mol-1)

deq (M)

Bt4131

53.84 ± 0.09

-3646.7

-1466.4

2.49

YbiV

55.41 ± 0.10

-5685.4

-1327.8

4.28

Chimera (Bt4131/YbiV)

33.04 ± 0.14

---

---

---

-2714.8

-1037.2

2.62

Protein

Chimera (YbiV/Bt4131)

Table 5.3: Table shows the denature values, thermal and chemical denature, for both the WT
and constructed chimera proteins (Bt4131/YbiV and YbiV/Bt4131).

5.3.6 The YbiV(core)/Bt4131(cap) Protein Has Native-Like Characteristics
A chimeric protein consisting of the core domain of YbiV and cap domain of
Bt4131 was prepared and subjected to studies probing its activity, folding ability and
stability. The results of chemical denaturation experiments indicate that this chimeric
protein is moderately stable. Although displaying no catalytic activity toward ribose-5phosphate, glucose-6-phosphate, or pNPP, the protein is marginally more stable than the
chimeric protein, Bt4131 (core)/YbiV(cap) as demonstrated by its handling
characteristics. While the difference between these two chimeric proteins could merely
reside in linker connections, it is possible that the difference is a consequence of the fact
that Bt4131 is less stable than YbiV (see above), and that the relative stabilities of the
chimeric proteins is a consequence of the characteristics of the core domains.
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5.4 Conclusion
The HAD proteins have evolved by incorporation of cap domains, which assists
substrate binding and creates diversity (3-7). In the effort described in this Chapter,
truncated and chimeric HAD proteins were prepared in order to examine the stabilities of
individual domains in HAD members. As seen by inspecting the results of investigations
of other proteins with multiple domains, in most cases the truncated proteins are more
stable (1). In contrast, the current studies show that core domains of the HADs have
stabilities that are similar to those of the native proteins. This observations demonstrates
that the Rossmann-like core domains of the HADs are robust, a possible reason why this
family tolerates cap domain changes that bring about substrate diversification.
Importantly, the stabilities of the truncated core proteins and their native HAD
counterparts respond to point mutations of active site residues in the same manner. In the
absence of the cap domain, capless YbiV core domain still undergoes folding through the
3-state pathway. The truncated cap domains of both Bt4131 and YbiV show similar
stability to the core domain truncations.
The chimeric proteins, in which the cap domains are switched with minimal
changes of linker residues, retain the ability to fold into ordered. This phenomenon
structures leads us to believe the HAD family is sufficiently robust to accommodate large
changes (for example electrostatics, domain interfacing surface interactions) in the
structures of cap domains. However, the YbiV-core/Bt4131-cap chimeric protein does
not retain the catalytic activities of either of its domain components. Thus, the stability of
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the structure of this chimeric protein serves supports a protein evolutionary model that
involves incorporation of recognition domains into catalytically active cores domains.
For this model to be evolutionarily applicable the core protein domain, like that in the
HADs, must be robust so that alterations of the recognition domains do not create
unacceptable levels of instability.
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CHAPTER SIX
STRUCTURAL INSGIHT: AN INVESTIGATION OF SOLUTION
CONFORMATION OF PYRUVATE PHOPSHATE DIKINASE
6.1 Introduction
Pyruvate phosphate dikinase (PPDK) is a multi-domain protein that reversible
catalyzes the conversion of ATP, inorganic phosphate, and pyruvate to AMP,
pyrophosphate and phosphoenolpyruvate (Figure 6.1). The protein in solution is a
monodimer (monomer MW ~96,000 Da) consisting of three separate domains: Nterminal nucleotide binding domain, central domain phosphocarrier, and C-terminal
PEP/pyruvate binding domain.

Figure 6.1: schematic represents the cycle through catalysis of PPDK.
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PPDK has been extensively characterized. The two predominant catalytic
conformations have been crystallized (PDB: 1DIK and 2R82) Figure 6.2. These two
structures differ by which domain is interacting with the phosphocarrier central domain.
To obtain the phosphocarrier central domain interacting with the PEP/pyruvate domain a
triple mutant was created to 'trap' the conformation (1).
Recent studies have shown that X-ray crystal structures do not always represent
accurate solution conformations (3-4). In this chapter we investigate modest differences
between X-ray structures and what is in solution. Experiments using small angle X-ray
scattering were used to observe solution conformations of PPDK. PPDK is an ideal
candidate for SAXS due to the size and unique conformations cycled through due to
catalysis.
In this chapter we will look at the differences in conformation due to detection
technique (X-ray crystallography and X-ray scattering) as well as investigate the
equilibrium state of the central domain in solution. We have X-ray structures showing
interaction between central domain and the two other domains, but what is the
equilibrium state of the central domain in solution? Does the central domain interact
closely to the rest of the protein structure or does the central domain 'float' in solution
until conformation changes summon interactions between domains.
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Figure 6.2: X-ray crystal structures of PPDK in both conformations (central domain
interacting with N-terminal or C-terminal domains. A. PDB: 1DIK, left: side view and right:
90º turn (central domain interacting with N-terminal) B. PDB: 2R82 left: side view and right:
90º turn (central domain interacting with C-terminal)
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6.2 Material and Methods
6.2.1 Materials
All restriction enzymes and T4 ligase were purchased from Invitrogen. Pfu Turbo
polymerase was purchased from Stratagene. Oligonucleotides were custom-synthesized
from Invitrogen. To verify correct sequence DNA sequencing was performed by MC labs
and MW mass spec determination was carried out by UNM Mass Spec Facilities.

6.2.2 Cloning and Purification of WT C. symbiosum PPDK
WT PPDK was grown from plasmid encoding the gene pACYC184-D12
according to 2. Cells were grown aerobically at 37 ºC (with agitation at 250 rpm)
containing 10 µg/mL tetracyclin in TB broth supplemented with 4 mL glycerol to an
O.D600 0.5-1.0 and induced for production of protein by adding 1mM IPTG (final
concentration). Following a 12 hour induction period at 17 ºC, cells were harvested by
centrifugation at 6,500 rpm for 10 minutes. Harvested cells were resuspended in 10x w/v
buffer A (50 mM HEPES, pH 7.5), and were lysed using a Amico French press at 1,200
psi, lysate was centrifuged at 20,000 rpm for 20 minutes. Protein was fractioned by
ammonium sulfate induced precipitation. The 50-90% ammonium sulfate fraction was
collected and centrifuged at 20,000 rpm for 20 minutes, the pellet was collected and resuspended in buffer B (50 mM HEPES 16% ammonium sulfate pH 7.5). The protein
solution was loaded onto a 10 x 300 mm (HR10 column) BS sepharose column, pre
equilibrated with Buffer B at 4o C. The column was washed with 10 COLUMN
VOLUME buffer B and protein was eluted with a linear gradient (10 CV) 100-0 % buffer
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B (16-0% (NH4)2SO4). The fractions containing the protein were collected and
concentrated using 50K Amicon Ultra centrifugal filters. Protein solution was dialyzed
with buffer A (3 rounds X 2L X2 hours each) to rid the solution of ammonium sulfate.
The dialyzed supernatant was loaded onto a DEAE sepharose column (10 X 300 mm
HR10 column) equilibrated with buffer A. the column was washed with 5 CV buffer A
and protein was eluted with a linear gradient from 0 - 1M KCl. Protein fractions were
collected and concentrated to load onto Size exclusion column (SEC) for buffer exchange
and final clean-up of sample. Final fractions were collected and concentrated. Protein
samples were stored at -80 oC. The protein yield was 10 mg protein/ 1 g wet cells.

6.2.3 Cloning and Purification of Δ340 PPDK
Δ340 PPDK protein was cloned using PCR amplification from the plasmid
pACYC184-D12 containing WT PPDK. PCR using pACYC184-D12 as a template and
Pfu

Turbo

polymerase.

Custom

AAGAGAACAGCTAGCGCTGCTCTTCAGATT,
TTTGCTCGAGAACTCTACGGAAGAAGGAT),

oligonucleotides
and

containing

(5`-

3`
the

restriction

endonuclease cleavage sites NheI and XhoI, were used in the PCR reactions. The pET28a
vector was cut by the restriction enzymes NheI and XhoI and ligated to the PCR product
that has been isolated and digested with the same restriction enzymes. The ligation
product (pET28a-Δ340 PPDK) was used to transform E. coli Iq competent cells.
The transformed cells were grown at 37 oC (with agitation at 250 rpm) in Terrific broth
(TB) containing 4 mL glycerol and 50 µg/mL kanamycin until OD600 reached
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approximately 0.6-1.0. The cells were induced overnight at 17o C with 1 mM IPTG. Cells
were harvested by centrifugation at 6,500 rpm for 10 minutes. Harvested cells were
resuspended in 10x w/v buffer A (50 mM HEPES, 200 mM NaCl, and 50 mM imidazole,
pH 7.5). Suspended cells were lysed using a Amico French press at 1,200 psi, cell lysate
was centrifuged at 4 oC for 20 minute at 20,000 rpm. Supernatant from centrifugation was
loaded onto a NTA-Ni HisTrap FF 5 mL column (GE Life Sciences). Column was
washed with buffer A to clean any un-bound protein and bound protein was eluted using
buffer B (50 mM HEPES, 200 mM NaCl, 500 mM imidazole pH 7.5). Column fractions
were tested for clean protein using SDS-page gel; all fractions containing clean protein
samples were combined and dialyzed at 4 ºC against 3 changes 2L/2L/4L of 50 mM
HEPES, 50 mM NaCl, 5mM MgCl2 pH 7.2. Protein yield was ~10 mg/g wet cells.

6.2.4 Purification of CentI PPDK
Truncated protein named CentI was created to express only the central domain of
the WT PPDK protein which included residues 382-503. Cells were grown from cell
stock encoding the His-tagged CentI protein. Cells were grown aerobically at 37 oC (with
agitation at 250 rpm) in Terrific broth (TB) containing 4 mL glycerol and 50 µg/mL
ampicillin to an O.D600 0.5-1.0 and induced for production of protein by adding 1 mM
IPTG (final concentration). Following a 12 hour induction period at 17 oC, cells were
harvested by centrifugation at 4oC for 10 minutes at 20,000 rpm. Cell pellet was
suspended in 10X w/v buffer A (50 mM HEPES, 200 mM NaCl, 50 mM imidazole pH
7.5). Supernatant was lysed using an Amico French press at 1,200 psi. Cell lysate was
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centrifuged at 4 oC for 20 minute at 20,000 rpm. Supernatant from centrifugation was
loaded onto a NTA-Ni HisTrap FF 5 mL column (GE Life Sciences). Column was
washed with buffer A to clean any un-bound protein and bound protein was eluted using
buffer B (50 mM HEPES, 200 mM NaCl, 500 mM imidazole pH 7.5). Column fractions
were tested for clean protein using SDS-page gel; all fractions containing clean protein
samples were combined and dialyzed at 4 ºC against 3 changes 2L/2L/4L of 50 mM
HEPES, 50 mM NaCl, 5mM MgCl2 pH 7.2. Protein yield was ~5 mg/g wet cells.

6.2.5 Purification of (R219E/E271R/S262D) PPDK
(R219E/E271R/S262D) PPDK was grown from cell stock encoding the gene
according to (1). Cells were grown aerobically at 37 ºC (with agitation at 250 rpm)
containing 10 µg/mL tetracyclin in TB broth supplemented with 4 mL glycerol to an
O.D600 0.5-1.0 and induced for production of protein by adding 1mM IPTG (final
concentration). Following a 12 hour induction period at 17 ºC, cells were harvested by
centrifugation at 6,500 rpm for 10 minutes. Harvested cells were suspended in 10x w/v
buffer A (50 mM HEPES, pH 7.5) and lysed using an Amico French press at 1,200 psi.
Lysate was centrifuged at 4 oC for 20 minutes at 20,000 rpm. Protein was fractioned by
ammonium sulfate induced precipitation. The 50-90% ammonium sulfate fraction was
collected and centrifuged at 4 oC for 20 minutes at 20,000 rpm, the pellet was collected
and re-suspended in buffer B (50 mM HEPES 16% ammonium sulfate pH 7.5). The
protein solution was loaded onto a 10 x 300 mm (HR10 column) BS sepharose column,
pre equilibrated with Buffer B at 4o C. The column was washed with 10 CV buffer B and
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protein was eluted with a linear gradient (10 CV) 100-0 % buffer B (16-0% (NH4)2SO4).
The fractions containing the protein were collected and concentrated using 50K Amicon
Ultra centrifugal filters. Protein solution was dialyzed with buffer A (3 rounds X 2L X2
hours each) to rid the solution of ammonium sulfate. The dialyzed supernatant was
loaded onto a DEAE sepharose column (10 X 300 mm HR10 column) equilibrated with
buffer A. the column was washed with 5 CV buffer A and protein was eluted with a
linear gradient from 0 - 1M KCl. Protein fractions were collected and concentrated to
load onto Size exclusion column (SEC) for buffer exchange and final clean-up of sample.
Final fractions were collected and concentrated. Protein samples were stored at -80 oC.
The protein yield was 12 mg protein/ 1 g wet cells.

6.2.6 Purification of Tem540 PPDK
Truncated protein Tem533 was created to express the N-terminal and central
domains of the WT PPDK protein which included residues 1-533. Cells were grown from
cell stock encoding TEm533 protein. Cells were grown aerobically at 37 oC (with
agitation at 250 rpm) in Terrific broth (TB) containing 4 mL glycerol and 50 µg/mL
ampicillin to an O.D600 0.5-1.0 and induced for production of protein by adding 1 mM
IPTG (final concentration). Cells were harvested by centrifugation at 4 oC for 10 minutes
at 6,500 rpm. Harvested cells were suspended in 10x w/v buffer A (50 mM HEPES, pH
7.5) and lysed using an Amico French press at 1,200 psi. Lysate was centrifuged at 4 oC
for 20 minutes at 20,000 rpm. Collected supernatant was loaded onto a DEAE sepharose
column (10 X 300 mm HR10 column) equilibrated with buffer A. Column was washed
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with 10 CV buffer A and protein was eluted using a linear gradient 0-100% buffer B (50
mM HEPES, 1 M KCl pH 7.5). Protein fractions were collected equilibrated with 16%
ammonium sulfate and loaded onto a BS sepharose column (10 X 300 mm HR10
column) equilibrated with buffer A (50 mM HEPES, 16% (NH4)2SO4 pH 7.5). Column
was washed with 5 CV buffer A and protein was eluted with linear gradient 0-100%
buffer B (50 mM HEPES pH7.5). Protein fractions were collected and concentrated using
a 30K Amicon Ultra Centrifugal filter. The final protein sample was loaded onto a size
exclusion column to buffer exchange and clean any residual contaminants. Purification
yielded 10 mg/g wet cells.

6.2.7 Purification of Tem340 PPDK
Truncated protein Tem340 PPDK was created to express the N-terminal domain
of the WT PPDK protein which included residues 1-340. Cells were grown from cell
stock encoding Tem340 protein. Cells were grown aerobically at 37 ºC (with agitation at
250 rpm) containing 50 µg/mL ampicillin in TB broth supplemented with 4 mL glycerol
to an O.D600 0.5-1.0 and induced for production of protein by adding 1mM IPTG (final
concentration). Following a 12 hour induction period at 17 ºC, cells were harvested by
centrifugation at 6,500 rpm for 10 minutes. Harvested cells were resuspended in 10x w/v
buffer A (50 mM HEPES, pH 7.5) were lysed using an Amico French press at 1,200 psi,
lysate was centrifuged at 20,000 rpm for 20 minutes. Protein was fractioned by
ammonium sulfate induced precipitation. The 40-90% ammonium sulfate fraction was
collected and centrifuged at 20,000 rpm for 20 minutes, the pellet was collected and re146

suspended in buffer B (50 mM HEPES 16% ammonium sulfate pH 7.5). The protein
solution was loaded onto a 10 x 300 mm (HR10 column) BS sepharose column, pre
equilibrated with Buffer B at 4o C. The column was washed with 10 CV buffer B and
protein was eluted with a linear gradient (10 CV) 100-0 % buffer B (16-0% (NH4)2SO4).
The fractions containing the protein were collected and concentrated using 50K Amicon
Ultra centrifugal filters. Protein solution was dialyzed with buffer A (3 rounds X 2L X2
hours each) to rid the solution of ammonium sulfate. The dialyzed supernatant was
loaded onto a DEAE sepharose column (10 X 300 mm HR10 column) equilibrated with
buffer A. the column was washed with 5 CV buffer A and protein was eluted with a
linear gradient from 0 - 1M KCl. Protein fractions were collected and concentrated to
load onto Size exclusion column (SEC) for buffer exchange and final clean-up of sample.
Final fractions were collected and concentrated. Protein samples were stored at -80 oC.
The protein yield was 5 mg protein/ 1 g wet cells.

6.2.8 Phosphorylation of PPDK and Δ340 PPDK
To investigate the solution conformation of the phosphorylated protein we need to
phosphorylate the catalytic histidine (H455). For the WT PPDK the 1st half reaction was
carried out in the absence of pyruvate. This was carried out according to the paper (5).
Mass Spec shows conversion from WT to phosphorylated enzyme Figure 6.3 and 6.4.
Reaction was checked periodically to determine complete phosphorylation.
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A similar process was carried out to phosphorylate Δ340 PPDK. Modification of the
above reaction included manipulating the 2nd partial reaction; PEP was added to protein
sample. Similar method was used to observe reaction over time.
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Figure 6.3: Mass Spec profile for phosphorylated PPDK. Secondary peak is the result of
cleavage of N-terminal Methionine
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Figure 6.4: Mass Spec profile for native PPDK. Secondary peak is the result of cleavage
of N-terminal Methionine
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6.2.9 Small angle X ray Analysis of Solution Conformations of PPDK
Synchrotron X-ray scattering data was collected at the SSRL 4-2 BioSAXS
beamline (SLAC, Menlo Park CA). The scattering patterns were tested at a range of
concentration to ensure a monodisperse solution. Data was collected with a MarCCD225
detector at wavelength of 1.3 A, at a distance of 1.7 m. Data processing and evaluation
was carried out using programs in the ATSAS package. Primary evaluation of parameters
was carried out using standard procedures in the PRIMUS package.

6.3 Results and Discussion
6.3.1 SAXS observed data shows modified quaternary structure compared to X-ray
crystal.
In cases involving proteins with large domain movement it has been normal to see
changes in solution conformation compared to X-ray crystal counterparts. In the event of
PPDK we know that the central domain swings from one domain to the other to complete
2 independent partial reactions. X-ray structure has been solved for both partial reactions
(central domain docked at both domains). The solution structure has been identified for
both conformations through site directed mutagenesis and substrate analog binding.
Theoretical scattering plots were created using CRYSOL (6). CRYSOL is used to
reverse calculate scattering curves from X-ray crystal structures. Figure 6.5 shows the
two scattering curves for PDB structures 1DIK and 2R82. From the scattering curves we
can see distinct differences between the two conformations.

151

6.5

log I

6.0
5.5
5.0
4.5
4.0
0.05

0.10

0.15

0.20

q
Figure 6.5: Theoretical scattering plot based on known PDB structures. BLACK: 1DIK
(central domain /C-terminal; RED: 2R82 (central domain /N-Terminal). Scattering
curves were generated using CRYSOL.

6.3.2 PPDK shows distinct solution conformations in native state upon binding 1st
partial reaction transition state intermediate: AMPPNP
The first partial reaction is the phosphorylation of the His455. The nucleotide
binding domain binds ATP to phosphorylate histidine. AMPPNP has previously been
shown to be a good inhibitor toward the 1st partial reaction. Binding AMPPNP (10x k i)
reveals a different solution conformation than the native PPDK (Figure 6.6-6.10)
Although results show that the native protein without any ligand shows a structure
similar to theoretical volume of central domain interacting with C-terminal domain
(2R82); when the native protein is tested with substrate analog AMPPNP the structure
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shifts to look more like the native X ray crystal structure (1DIK) in which the central
domain is interacting with the N-terminal domain.
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Figure 6.6: Native PPDK with and with Substrate inhibitor AMPPNP. The protein shows a
shift in conformational structure when in the presence of ligand. BLACK: native protein
without AMPPNP, RED: native protein with AMPPNP.

153

6.5

log I

6.0
5.5
5.0
4.5
4.0
0.05

0.10

0.15

0.20

q
Figure 6.7: Experimental scattering curve of native PPDK without substrate, AMPPNP
compared to PDB generated scattering curves. BLACK: 1DIK (central domain /Cterminal; RED: 2R82 (central domain /N-Terminal); and GREEN: Experimental data.

6.5

log I

6.0
5.5
5.0
4.5
4.0
0.05

0.10

0.15

0.20

q
Figure 6.8: Experimental scattering curve of native PPDK with substrate, AMPPNP
(10X Ki) compared to PDB generated scattering curves. BLACK: 1DIK (central domain
/C-terminal; RED: 2R82 (central domain /N-Terminal); and GREEN: Experimental data.
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Figure 6.9: Experimental scattering curve of phosphorylated PPDK without substrate,
AMPPNP compared to PDB generated scattering curves. BLACK: 1DIK (central domain
/C-terminal; RED: 2R82 (central domain /N-Terminal); and GREEN: Experimental data.
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Figure 6.10: Experimental scattering curve of phosphorylated PPDK with substrate,
AMPPNP (10X Ki) compared to PDB generated scattering curves. BLACK: 1DIK
(central domain /C-terminal; RED: 2R82 (central domain /N-Terminal); and GREEN:
Experimental data.
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6.3.3 PPDK shows two distinct conformations according to phosphorylation of His455
Solution conformations were observed using SAXS of both the native PPDK and
the phosphorylated structures. From known X ray structures (PDB: 1DIK and 2R82) we
see PPDK in two distinct conformations: N-terminal/central domain and Cterminal/central domain.
Both samples were tested at a variety of concentrations (0.5 -30 mg/mL) to ensure
no concentration dependence. There are four possible conformational changes: native:
empty, native: substrate, phosphorylated: empty, and phosphorylated: substrate. From the
observed scattering we see two predominant structures (Table 6.1, Figure 6.11). The
structures seen are from the native PPDK with substrate analog AMPPNP and the three
other combinations showing the other scattering volumes.
From the scattering experiments we can see that that the native PPDK shows
conformation similar to the phosphorylated PPDK structures. While the native structure
shows two separate conformations, the phosphorylated central domain have only one
conformation regardless of empty or bound substrate analog (oxelate).
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1

WT

EMPTY

43.804 ± 0.413

45.96

153.32

AMPNP

41.415 ± 0.599

43.76

144.95

EMPTY

41.449 ± 1.226

43.41

145.07

Oxelate/Mn2+

42.785 ± 0.471

44.48

149.75

EMPTY

22.851 ± 0.150

22.81

79.98

AMP

21.795 ± 0.191

21.74

75.78

AMPPNP

22.253 ± 0.158

22.10

72.88

EMPTY

32.109 ± 0.353

32.58

112.38

AMP

30.163 ± 0.857

30.44

105.57

AMPNP

29.471 ± 0.856

29.92

103.15

EMPTY

16.907 ± 1.599

17.72

63.17

Tem340 PPDK

Tem540 PPDK

Cent PPDK

Rg

2

Ligand

Phosphorylated PPDK

Rg

2

Protein

Table 6.1: Displayed are all the scattering values for the PPDK constructs
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Figure 6.11: P(r) distributions of native and phosphorylated PPDK with/without substrate
analogs. GREEN: native PPDK without substrate analog (AMPPNP), BLUE: native PPDK
with substrate analog (AMPPNP), BLACK: phosphorylated PPDK without substrate analog
(oxelate), and RED: phosphorylated PPDK with substrate analog (oxelate).

6.3.4 Nucleotide binding domain shows closure upon introduction of substrate and
analogs
The N-terminal domain consisting of residues 1-340 fold into a nucleotide
binding domain where the 1st partial reaction occurs; transfer of -phosphoryl of ATP to
hisitne (455) forming a pyrophosphorylated enzyme intermediate. Scattering data shows
conformational change in nucleotide binding domain upon binding substrate analog AMP
and transition state analog AMPPNP. SAXS studies show 3 distinct conformation
(empty, AMP, AMPNP) suggesting conformational change due to activity. The
nucleotide binding domain goes through a closure upon binding substrate this can be
observes from the decrease in size (as seen through Rg and volume max, dmax) as
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substrates bind from empty>AMP>AMPNP,

Figure 6.12 and Table 6.1 shows the

modification in P (r) distribution according to binding.
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Figure 6.12: Truncated PPDK, Tem340, w/wo substrate analogs. BLACK: Tem340 empty,
RED: Tem340 with substrate analog (AMP), and GREEN: Tem340 with substrate analog
(AMPPNP).

6.3.5 Truncated PPDK (Tem540) shows modification in volume due to ligand
binding.
Tem 540 is a truncated mutant of PPDK in which the C-terminal domain in
cleaved. SAXS was collected on the truncated protein in the absence and presence of
AMP and AMPNP to identify change in the conformation of the protein; more
specifically does central domain interact with the N-terminal or is it in solution. SAXS
data shows a decrease in dmax upon ligand introduction (empty>AMP=AMPPNP) with
empty having the largest dmax.
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When looking at solution conformations of proteins with drastic domain shifts, it
is important to identify equilibrium positions. This truncation was used to investigate if
the central domain would interact with the N-terminal domain without the presence of the
C-terminal domain. We have already seen that the central domain possibly sets close to
the C-terminal domain at equilibrium but as ligands are introduced the conformation
shifts to the central/N-terminal conformation.
From the collected scattering data we can see the protein created a larger volume
when compared to the N-terminal alone, dmax of 79.98 to 112.38 nm for TEM340 and
TEM540 PPDK respectively. From creating theoretical distances, longest distances from
end-to-end from PDB structures, of the central domain interacting w/wo N-terminal
domain we have concluded that the largest distance is from ~94 nm for 2R82 in which
central domain is interacting with C-terminal, and ~75 nm for 1DIK (central + Nterminal) (Figure 6.13).

Figure 6.13: Theoretical Tem540 truncations created by deleting N-terminal domain of
known PDBs (MAGENTA: 2R82 and BLUE: 1DIK). Distances were created to create
estimate of dmax in PDB structures. 2R82 longest distance ~92 nm and 1DIK longest distance
~70 nm.

From the dmax derived from the calculated protein volumes we see that the central
domain indeed does not interact in the same way as our theoretical models. This holds
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both good news and bad news, as our models are created from using truncated X ray
structures which does not accurately portray how the protein acts without the N-terminal
domain, although our lengths are larger than the theoretical, it does tell us that the central
domain in solution does not interact as closely as thought (Figure 6.14)

Figure 6.14: Displayed volumes with truncated PDB structures fit to volumes. BLUE X ray
crystal structures are the N-terminal domain from PDB: 2R82 and MAGENTA: X ray crystal
structure of central domain (PDB: 2FM4. Volumes (left to right) are TEM540 with substrate
analog From
AMPPNP
withwe
substrate
analog AMPPNP
the and
dataTEM340
collected
can conclude
that although the central domain in

solution of the Tem540 PPDK truncation does not interact closely we do see 'closure' of
the dmax length upon ligand binding.
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6.3.6 Truncated central domain folds completely
The central domain is responsible for connecting the two partial reactions. It has
previously been characterized and crystallized separately (PDB: 2FM4). For
completeness and to investigate the structure in solution SAXS data was collected on
CentI PPDK domain Figure 6.15.
Scattering data supports a folded central domain. Figure 6.16 shows PDB 2FM4
fit into solution volume created from central domain scattering data. Protein was used to
investigate interaction between it and TEM340 PPDK truncation.
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Figure 6.15: Scattering plot of CentI.
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Figure 6.16: Central domain of PPDK (PDB: 2FM4) fit within calculated volume from
scattering data.

6.4 Conclusion
PPDK has been thoroughly investigated mechanistically, but some questions have
yet to be answered. The central domain swings between the two other domains and
connects two partial reactions, but how does the domain interact and move between
domains? There are two possibilities in which the central domain can move: 1. move
through solution between the two reaction centers or 2. 'roll' between reaction centers
while continuously making contact with protein. To investigate the conformational
changes in PPDK SAXS was used.
From the collected scattering data we can see that the PPDK's solution
conformations are not as cut and dry as the two published structures (PDB 1DIK and
2R82). We can see that the protein in the native form has a conformation similar to
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PDB:2R82 rather than 1DIK. From our data we see that the native PPDK conformation
equilibrium favors the PDB: 2R82 structure when substrate analog is not present, but
when present the other conformation is favored (PDB: 1DIK), after phosphorylation of
His455 the 2R82 structure is favored again.
From the truncated domains we see folded functional forms of both the Nterminal grasp domain and central domains. From the N-terminal domain separate we can
identify change in conformation due to binding. The more unique truncation of the
bundle is the N-terminal-central domain truncation (Tem540 PPDK). From the SAXS
data collected on the Tem540 PPDK construct we can see an elongated structure when
compared to the N-terminal only which suggests minimal interactions among the two
domains. Although we cannot rule out interaction the SAXS data allows us to infer the
central domain may transverse through solvent between active sites rather along the
protein surface. For a complete picture deletion mutations of linkers between central
domain and rest of protein will be addressed to investigate solution conformation and
position of central domain compared to native and phosphorylated PPDK.
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